This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Lichen planus
L12_LICHENPLANUS
lichen planus: A lichen disease that is located_in skin, located_in tongue or located_in oral mucosa, which presents itself in the form of papules, lesions or rashes. The cause is not known.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
5095 |
4. Check minimum number of eventsNone |
5095 |
5. Include endpointsNone |
5095 |
6. Filter based on genotype QC (FinnGen only) |
5095 |
Control definitions (FinnGen only)
- Control exclude
- L12_PAPULOSQUAMOUS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L40-L45
- Name in latin
- Lichen planus
Similar endpoints
↥List of similar endpoints to
Lichen planus
based on the number of shared cases.
Similar with more cases:
- Lichen planus, including avohilmo
- Lichen ruber planus, wide definition including periferal and oral lichen planus
- Papulosquamous disorders
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5095 | 3391 | 1704 |
| Unadjusted period prevalence (%) | 1.02 | 1.16 | 0.75 |
| Median age at first event (years) | 58.39 | 58.83 | 57.51 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4558
- Matched controls
- 45578
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L43.8
ICD-10 Finland
Other lichen planus
967.4
323.0
2334
48
L43.9
ICD-10 Finland
Lichen planus, unspecified
296.5
323.0
2024
123
EKA10
NOMESCO Finland
Biopsy of cheek
19.7
323.0
566
325
D07AD01
ATC
clobetasol; topical
8.2
323.0
1994
3954
L43
ICD-10 Finland
Lichen planus
34.7
323.0
455
145
L43.0
ICD-10 Finland
Hypertrophic lichen planus
801.5
323.0
684
10
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
29.4
323.0
517
197
D07AC01
ATC
betamethasone; topical
5.0
323.0
2721
10349
D07AC13
ATC
mometasone; topical
3.4
293.0
1993
8489
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.1
267.7
953
2237
E0000UV
ATC
NA
2.9
249.3
2360
12225
L43.3
ICD-10 Finland
Subacute (active) lichen planus
501.7
241.7
239
5
D05BB02
ATC
acitretin; oral
20.7
190.7
290
149
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.2
189.5
1221
4681
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
7.5
175.2
440
642
D07AB02
ATC
hydrocortisone butyrate; topical
2.6
170.6
1678
8312
L43.1
ICD-10 Finland
Bullous lichen planus
550.4
162.0
160
*
SBA00
NOMESCO Finland
Microbiological examinations
8.3
151.1
351
451
E000001
ATC
NA
2.7
139.5
1186
5278
L40.0
ICD-10 Finland
Psoriasis vulgaris
21.7
134.1
200
96
A01AC01
ATC
triamcinolone; local oral
9.7
132.8
280
304
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
7.1
127.4
328
491
ECA20
NOMESCO Finland
Biopsy of gingiva
14.0
127.2
224
168
A07AA02
ATC
nystatin; oral
4.0
124.7
546
1493
SAA03
NOMESCO Finland
Extended examination of mouth
2.2
123.7
1931
11543
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
8.0
119.5
284
376
N77.8*L43.9
ICD-10 Finland
Vulvovaginal ulceration and inflammation caused by lichen ruber planus
177.5
115.9
121
7
69700
ICD-8 Finland
Lichen, Planus
+∞
107.7
103
*
K13.29
ICD-10 Finland
Indefinite leukoplakia
11.0
105.3
207
196
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
16.1
98.4
163
105
H02AB06
ATC
prednisolone; systemic
1.9
94.8
2309
15894
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.1
94.4
1439
8259
L43.2
ICD-10 Finland
Lichenoid drug reaction
926.9
93.2
91
*
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
6.1
89.7
257
442
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.9
87.7
584
2172
ULA02
NOMESCO Finland
Kolposcopy
3.0
86.1
547
1968
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.0
85.4
366
969
D07AB08
ATC
desonide; topical
2.8
82.3
608
2409
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.1
81.6
1220
6864
XQ802
NOMESCO Finland
Epicutan test
4.4
81.1
310
736
D09AB01
ATC
zinc bandage without supplements; topical
6.8
75.8
199
304
TQW80
NOMESCO Finland
Local dermatologic skincare
5.7
74.6
226
416
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.6
72.1
350
1028
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
4.4
70.8
272
648
J02AC01
ATC
fluconazole; systemic
1.8
69.8
1937
13418
A01AB09
ATC
miconazole; local oral
2.6
66.2
556
2353
LEB00
NOMESCO Finland
Biopsy of vagina
6.2
64.6
182
306
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
64.3
3083
24911
K13.20
ICD-10 Finland
Idiopathic leukoplakia
15.9
62.5
103
66
L28.0
ICD-10 Finland
Lichen simplex chronicus
9.7
61.3
128
136
D07XC01
ATC
betamethasone, combinations; topical
2.4
60.4
560
2493
D05AX52
ATC
calcipotriol, combinations; topical
4.2
60.0
240
594
SAA02
NOMESCO Finland
Basic examination of mouth
1.7
59.7
2747
21668
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
59.6
1542
10299
E000002
ATC
NA
2.4
58.0
557
2522
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.1
57.2
336
1134
R06AE07
ATC
cetirizine; oral
1.7
57.1
1984
14400
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
60.8
56.5
66
11
XQ848
NOMESCO Finland
Dermatological photography
4.7
55.7
199
440
B37.08
ICD-10 Finland
Other candidal stomatitis
11.2
53.0
102
93
E000006
ATC
NA
2.6
52.3
408
1648
K13.78
ICD-10 Finland
Other change in the oral mucosa
5.0
52.2
175
362
6970A
ICD-9 Finland
Lichen planus[LICHEN RUBER PLANUS]
+∞
51.1
49
*
SXA10
NOMESCO Finland
Epithel biopsy of mouth
6.5
47.6
127
199
D02AE01
ATC
carbamide; topical
2.6
47.0
360
1435
J01DB01
ATC
cefalexin; oral
1.7
45.7
3610
31597
A01AB04
ATC
amphotericin B; local oral
2.8
44.4
308
1156
R06AX27
ATC
desloratadine; oral
1.7
44.1
1148
7538
B37.03
ICD-10 Finland
Chronic atrophic candida infection in the mouth
17.5
43.6
69
40
D07BC01
ATC
betamethasone and antiseptics; topical
2.0
43.2
599
3172
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.0
41.0
584
3120
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
11.0
40.9
79
73
N76.3
ICD-10 Finland
Subacute and chronic vulvitis
8.1
39.6
91
115
R01AD11
ATC
triamcinolone; nasal
2.1
39.0
465
2309
K13.22
ICD-10 Finland
Erythroplakia of oral epithelium, including tongue
22.2
37.8
55
25
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
37.5
2333
18775
D07CC01
ATC
betamethasone and antibiotics; topical
1.9
36.7
597
3348
D05AX02
ATC
calcipotriol; topical
4.1
36.3
147
369
N77.8
ICD-10 Finland
Vulvovaginal ulceration and inflammation in other diseases classified elsewhere
60.5
36.2
42
7
L40.5
ICD-10 Finland
Arthropathic psoriasis
27.5
35.9
49
18
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
35.0
1279
9087
R06AE09
ATC
levocetirizine; oral
1.8
34.5
640
3749
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.8
34.1
237
891
D07AC14
ATC
methylprednisolone aceponate; topical
2.7
33.9
245
942
E000007
ATC
NA
2.6
33.8
269
1091
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
33.8
1697
12938
R01AD09
ATC
mometasone; nasal
1.5
33.3
1885
14729
R03AC02
ATC
salbutamol; inhalant
1.5
33.0
2212
17877
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.1
32.8
407
2050
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
31.5
2323
19063
J01DA01
ATC
[U] cefalexin; systemic
1.4
31.2
2679
22626
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
31.2
2168
17567
WX110
NOMESCO Finland
Local anesthesy
1.4
30.8
2855
24447
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
30.6
1984
15835
S29
ICPC
Skin symptom/complaint other
1.7
30.3
741
4712
A02BC02
ATC
pantoprazole; systemic
1.4
30.2
2862
24561
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.9
30.1
484
2690
N02BE01
ATC
paracetamol; systemic, rectal
1.6
30.1
3822
34897
K12.10
ICD-10 Finland
Stomatitis NOS
8.8
30.1
65
75
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.8
30.0
578
3415
J01AA02
ATC
doxycycline; systemic
1.5
30.0
3449
30763
D07AA02
ATC
hydrocortisone; topical
1.8
29.8
547
3181
J02AC02
ATC
itraconazole; systemic
1.6
29.6
814
5344
SDA02
NOMESCO Finland
Parodonthologic therapy
1.5
29.0
1349
10029
UJF32
NOMESCO Finland
Coloscopy
1.5
29.0
1150
8256
XQ800
NOMESCO Finland
Prick test
2.1
28.7
325
1572
N89.5
ICD-10 Finland
Stricture and atresia of vagina
18.5
28.7
44
24
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
18.9
28.2
43
23
J01CA04
ATC
amoxicillin; systemic
1.5
27.5
3399
30391
L40.8
ICD-10 Finland
Other psoriasis
21.2
27.3
40
19
S18
ICPC
Laceration/cut
1.4
26.9
1789
14230
A02BC05
ATC
esomeprazole; systemic
1.4
26.7
1795
14302
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
26.6
1850
14830
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
26.2
1099
7957
M79.6
ICD-10 Finland
Pain in limb
1.4
26.1
1505
11630
TEA00
NOMESCO Finland
Biopsy of lip
5.1
25.8
83
166
N02AX02
ATC
tramadol; systemic, rectal
1.4
25.7
1781
14237
SPAT1153
SPAT
Removal of sutures
1.4
25.5
1378
10503
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
25.3
1842
14846
J01FF01
ATC
clindamycin; systemic
1.5
25.3
1126
8249
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
25.2
902
6290
SPAT1263
SPAT
Sampling
1.4
25.2
1765
14121
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
25.1
1833
14774
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
8.9
24.9
53
60
N05BB01
ATC
hydroxyzine; systemic
2.1
24.7
293
1443
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
24.7
1407
10821
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.5
24.6
1004
7213
R01AD08
ATC
fluticasone; nasal
1.5
24.5
1169
8677
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.4
24.4
1468
11401
D02AX
ATC
Other emollients and protectives
2.9
24.1
150
526
A02BC03
ATC
lansoprazole; oral
1.4
24.0
1290
9798
K02.1
ICD-10 Finland
Caries of dentine
1.4
23.8
2208
18488
P01AB01
ATC
metronidazole; oral, rectal
1.4
23.7
1671
13339
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.9
23.4
340
1814
M01AC06
ATC
meloxicam; systemic, rectal
1.4
23.4
1615
12835
L66.1
ICD-10 Finland
Lichen planopilaris
28.4
23.1
31
11
M25.5
ICD-10 Finland
Pain in joint
1.4
23.0
1158
8670
KMAK
NOMESCO Finland
NA
1.4
22.9
2056
17074
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
22.6
850
5979
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
2.8
22.5
151
558
L28.1
ICD-10 Finland
Prurigo nodularis
6.4
22.4
59
93
SPAT1301
SPAT
No procedures
1.4
22.3
1318
10162
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.7
22.3
467
2823
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
22.1
1493
11788
EHA10
NOMESCO Finland
Biopsy of palate
6.4
22.1
58
91
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
22.1
1227
9350
G01AA10
ATC
clindamycin; vaginal
1.6
22.0
632
4167
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.8
21.7
391
2251
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
21.7
1147
8653
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
13.9
21.3
36
26
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
21.2
1004
7402
TLE00
NOMESCO Finland
Dilatation of vagina
77.1
20.7
23
*
K12.18
ICD-10 Finland
Other forms of stomatitis
5.5
20.6
61
112
L17
ICPC
Foot/toe symptom/complaint
1.4
20.5
1039
7760
EBA00
NOMESCO Finland
Extraction of tooth
1.4
20.5
1254
9700
H03AA01
ATC
levothyroxine sodium; systemic
1.4
20.4
1061
7962
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.2
20.3
205
939
-1
NOMESCO Finland
NA
1.4
20.3
1247
9647
R06.0
ICD-10 Finland
Dyspnoea
1.4
20.3
1005
7467
M03BX02
ATC
tizanidine; oral
1.3
20.3
2582
22482
R01AD01
ATC
beclometasone; nasal
1.6
20.2
639
4308
SPAT1310
SPAT
Counselling related to known health issue
1.4
20.2
1318
10305
SPAT1312
SPAT
General health counselling
1.4
20.1
1267
9843
M01AH05
ATC
etoricoxib; oral
1.3
20.1
2462
21298
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
4.9
20.0
66
137
SBB10
NOMESCO Finland
Teeth copy
2.1
19.7
227
1104
J01FA10
ATC
azithromycin; systemic
1.3
19.5
2312
19859
L40.9
ICD-10 Finland
Psoriasis, unspecified
7.2
19.5
47
66
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
4.4
19.5
71
164
A07EA02
ATC
hydrocortisone; rectal
3.0
19.4
117
402
N03AX16
ATC
pregabalin; oral
1.4
19.4
993
7417
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
19.1
1579
12820
A02BA02
ATC
ranitidine; systemic
1.5
19.0
850
6182
N48.1
ICD-10 Finland
Balanoposthitis
3.4
18.9
93
279
E000003
ATC
NA
2.3
18.8
180
807
A02BC01
ATC
omeprazole; systemic
1.4
18.8
1139
8772
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
15.9
18.8
30
19
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
18.7
477
3045
M07.3
ICD-10 Finland
Other psoriatic arthropathies
18.8
18.6
28
15
N03AX12
ATC
gabapentin; oral
1.5
18.6
645
4438
L30.0
ICD-10 Finland
Nummular dermatitis
2.5
18.6
151
622
WZA90
NOMESCO Finland
Other doctors statement
1.4
18.5
884
6507
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.8
18.5
361
2131
SFA00
NOMESCO Finland
Small filling
1.6
18.4
502
3258
J01MA02
ATC
ciprofloxacin; systemic
1.3
18.4
1555
12642
P01BA02
ATC
hydroxychloroquine; oral
1.7
18.4
377
2259
C05AA08
ATC
fluocortolone; rectal, topical
1.5
18.2
608
4146
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.9
18.2
257
1361
S21
ICPC
Skin texture symptom/complaint
1.6
18.0
501
3266
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.4
17.9
938
7019
L40
ICD-10 Finland
Psoriasis
5.5
17.9
53
98
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
17.9
652
4537
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.6
17.8
446
2829
B37.01
ICD-10 Finland
Acute athrophy candidal stomatitis
11.9
17.8
32
27
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
+∞
17.7
17
*
A07EC01
ATC
sulfasalazine; oral, rectal
1.8
17.7
322
1858
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
7.5
17.6
41
55
M54.5
ICD-10 Finland
Low back pain
1.4
17.5
1284
10188
D05AX03
ATC
calcitriol; topical
6.3
17.4
46
74
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.7
17.3
119
446
EMAK
NOMESCO Finland
NA
2.3
17.3
166
744
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
17.3
2005
17045
Z01.2
ICD-10 Finland
Dental examination
1.3
17.2
1584
13016
SPAT1260
SPAT
Consultation of another employee
1.5
17.2
724
5189
A46
ICD-10 Finland
Erysipelas
1.6
17.2
523
3488
K12.00
ICD-10 Finland
Recurrent oral aphthae
3.7
17.0
75
207
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
6.4
17.0
44
69
L93.0
ICD-10 Finland
Discoid lupus erythematosus
6.2
16.9
45
73
L30.8
ICD-10 Finland
Other specified dermatitis
2.8
16.8
109
397
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
16.7
559
3810
L40.4
ICD-10 Finland
Guttate psoriasis
35.1
16.6
21
6
J01FA09
ATC
clarithromycin; systemic
1.4
16.6
1255
9990
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
16.5
1853
15641
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.6
16.4
125
498
R13
ICD-10 Finland
Dysphagia
1.8
16.2
270
1514
XQ845
NOMESCO Finland
Dermatoscopy
3.4
16.2
77
226
D06BX01
ATC
metronidazole; topical
1.6
16.2
425
2727
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
5.0
16.2
51
102
D07AC03
ATC
desoximetasone; topical
3.1
16.0
87
282
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
16.0
952
7273
A01AB10
ATC
natamycin; local oral
2.4
16.0
132
551
EJ2S1
NOMESCO Finland
Photography of oral mucosa
10.1
15.9
31
31
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
15.6
1491
12271
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
15.6
763
5622
J01FA06
ATC
roxithromycin; oral
1.3
15.5
1658
13861
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.3
15.5
2130
18433
SBA10
NOMESCO Finland
Measurement of excretion of saliva
4.1
15.4
60
149
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.4
15.3
878
6658
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
15.3
413
2670
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
15.2
542
3741
SXC03
NOMESCO Finland
Other oral or dental procedure
3.7
15.2
65
176
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.4
15.1
968
7479
R03BA01
ATC
beclometasone; inhalant
1.5
15.1
566
3949
H02AB04
ATC
methylprednisolone; systemic
1.5
14.9
593
4191
WX290
NOMESCO Finland
Other blockade of nerve
1.3
14.9
1552
12909
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.4
14.9
895
6843
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.5
14.9
113
453
L03
ICPC
Low back symptom/complaint
1.4
14.7
942
7277
G47.3
ICD-10 Finland
Sleep apnoea
1.4
14.6
788
5908
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
3.1
14.6
78
251
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
14.6
1275
10335
SPAT1325
SPAT
Vaccination
1.3
14.5
1369
11222
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
14.4
1183
9497
L30.3
ICD-10 Finland
Infective dermatitis
2.3
14.4
134
597
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.7
14.3
295
1771
EAA10
NOMESCO Finland
Excision of lesion of lip
3.7
14.3
62
170
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
14.2
1680
14194
J05AB01
ATC
aciclovir; systemic
1.4
14.2
827
6282
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.9
14.1
212
1149
S99
ICPC
Skin disease other
2.7
14.1
93
344
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
14.1
1582
13273
R06AX22
ATC
ebastine; oral
1.4
14.1
652
4746
D82
ICPC
Teeth/gum disease
1.3
13.9
1247
10132
K13.2
ICD-10 Finland
Leukoplakia and other disturbances of oral epithelium, including tongue
8.8
13.9
29
33
S02
ICPC
Pruritus
2.2
13.9
135
612
L44.3
ICD-10 Finland
Lichen ruber moniliformis
53.5
13.8
16
*
D07AB01
ATC
clobetasone; topical
2.2
13.8
138
636
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.6
13.8
378
2452
M01AB05
ATC
diclofenac; systemic, rectal
1.3
13.8
2755
24850
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
13.5
457
3114
K07.60
ICD-10 Finland
Snapping jaw
2.0
13.5
175
897
N76.1
ICD-10 Finland
Subacute and chronic vaginitis
3.2
13.5
70
221
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
13.5
996
7854
M70.6
ICD-10 Finland
Trochanteric bursitis
1.5
13.4
536
3787
LFA00
NOMESCO Finland
Incision of vulva or perineum
10.0
13.4
26
26
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
13.4
876
6776
N06AX11
ATC
mirtazapine; oral
1.3
13.4
1230
10019
N90.4
ICD-10 Finland
Leukoplakia of vulva
6.8
13.4
33
49
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
13.4
510
3569
R01AD12
ATC
fluticasone furoate; nasal
1.3
13.4
1070
8541
KGB00
NOMESCO Finland
Biopsy of penis
18.2
13.3
20
11
L29.2
ICD-10 Finland
Pruritus vulvae
3.3
13.3
67
207
EKB00
NOMESCO Finland
Excision of lesion of cheek
7.3
13.2
31
43
A98
ICPC
Health maint/preventive medicine
1.5
13.2
4232
40766
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.6
13.0
394
2617
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.4
13.0
111
474
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
13.0
564
4055
SXC05
NOMESCO Finland
Other oral or dental procedure
1.8
13.0
208
1152
K05.30
ICD-10 Finland
Periodontitis complex
1.5
12.9
485
3380
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
12.9
3805
35967
L57.0
ICD-10 Finland
Actinic keratosis
1.6
12.8
385
2556
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
12.7
1527
12874
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
12.7
725
5476
R05
ICPC
Cough
1.4
12.7
850
6594
K13.21
ICD-10 Finland
Leukoplakia caused by tobacco
9.0
12.7
26
29
D01BA02
ATC
terbinafine; oral; topical
1.3
12.7
953
7530
D19
ICPC
Teeth/gum symptom/complaint
1.3
12.6
926
7290
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
12.6
402
2707
K05.31
ICD-10 Finland
Periodontitis pronounced
1.5
12.6
380
2527
M01AE02
ATC
naproxen; oral, rectal
1.3
12.5
2231
19730
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
12.5
2698
24400
Z70.8
ICD-10 Finland
Other sex counselling
11.0
12.5
23
21
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
12.5
1668
14245
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
5.6
12.3
35
63
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
12.3
382
2553
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
12.3
856
6675
H02AB07
ATC
prednisone; oral
1.4
12.2
557
4037
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
10.5
12.2
23
22
G04BD12
ATC
mirabegron; oral
1.5
12.2
408
2776
L08
ICPC
Shoulder symptom/complaint
1.4
12.1
748
5720
N06AX21
ATC
duloxetine; oral
1.5
12.0
412
2817
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.6
12.0
278
1727
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
12.0
268
1649
R52.9
ICD-10 Finland
Pain, unspecified
1.6
12.0
311
1991
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.6
12.0
306
1950
L04AB04
ATC
adalimumab; parenteral
2.9
11.9
70
242
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
11.9
676
5101
E000004
ATC
NA
2.6
11.8
83
320
L29.9
ICD-10 Finland
Pruritus, unspecified
2.4
11.8
99
420
A07EA06
ATC
budesonide; oral, local oral
2.0
11.7
141
703
N05CF02
ATC
zolpidem; oral
1.4
11.6
691
5250
M01AX17
ATC
nimesulide; oral
1.3
11.6
1019
8221
S91
ICPC
Psoriasis
6.9
11.6
28
41
R51.80
ICD-10 Finland
Headache
1.4
11.6
508
3656
S01
ICPC
Pain/tenderness of skin
1.9
11.5
167
897
M02AA07
ATC
piroxicam; topical
1.3
11.5
1523
12963
EDB00
NOMESCO Finland
Partial excision of mandible
10.0
11.5
22
22
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.5
11.5
425
2956
S08
ICPC
Skin colour change
1.8
11.5
197
1118
L44.1
ICD-10 Finland
Lichen nitidus
120.3
11.4
12
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
11.4
920
7330
KGH10
NOMESCO Finland
Operation for phimosis
2.6
11.4
83
325
R03BA05
ATC
fluticasone; inhalant
1.4
11.4
671
5091
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
11.4
943
7544
L50.3
ICD-10 Finland
Dermatographic urticaria
2.8
11.4
71
255
N06AA09
ATC
amitriptyline; systemic
1.5
11.3
411
2847
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.7
11.3
227
1354
M48.0
ICD-10 Finland
Spinal stenosis
1.4
11.2
485
3480
J01MA12
ATC
levofloxacin; systemic
1.4
11.1
682
5209
R03DC03
ATC
montelukast; oral
1.4
11.1
591
4404
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.4
11.1
505
3659
L73.8
ICD-10 Finland
Other specified follicular disorders
4.1
11.1
42
104
L04AX01
ATC
azathioprine; systemic
1.9
11.0
171
938
J01AA07
ATC
tetracycline; systemic
1.4
11.0
507
3681
R03BA02
ATC
budesonide; inhalant
1.4
11.0
650
4934
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.6
11.0
320
2107
D01AC02
ATC
miconazole; topical
1.6
11.0
288
1850
G44.2
ICD-10 Finland
Tension-type headache
1.4
10.9
487
3513
L20.0
ICD-10 Finland
Besnier prurigo
1.8
10.9
189
1078
UKC02
NOMESCO Finland
Cystoscopy
1.4
10.9
548
4041
SPAT1240
SPAT
Therapeutic discussion
1.5
10.9
324
2145
L15
ICPC
Knee symptom/complaint
1.3
10.8
822
6488
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.3
10.8
93
402
J01EA01
ATC
trimethoprim; systemic
1.3
10.7
992
8047
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
10.7
424
2986
SPAT1058
SPAT
PEF monitoring instruction
1.5
10.7
322
2138
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.4
10.7
696
5364
J01AA04
ATC
lymecycline; systemic
1.5
10.7
425
2998
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.3
10.7
888
7100
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
10.6
646
4921
K13.03
ICD-10 Finland
Keilit UNS
7.5
10.6
24
32
R74
ICPC
Upper respiratory infection acute
1.3
10.6
916
7364
N76.6
ICD-10 Finland
Ulceration of vulva
3.9
10.5
42
109
R96
ICPC
Asthma
1.5
10.5
336
2262
A07EC02
ATC
mesalazine; oral, rectal
1.8
10.5
194
1127
L04AD01
ATC
ciclosporin; systemic
2.7
10.4
70
263
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.9
10.4
148
792
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.7
10.4
205
1219
B37.02
ICD-10 Finland
Chronic hyperplastic candidal stomatitis
16.1
10.3
16
10
-
ICD-10 Finland
NA
2.2
10.3
100
455
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.5
10.3
385
2681
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
10.3
498
3650
R05
ICD-10 Finland
Cough
1.3
10.3
726
5663
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
10.3
271
1744
B35.3
ICD-10 Finland
Tinea pedis
1.9
10.2
139
731
K03.00
ICD-10 Finland
Approximal wear
1.8
10.2
177
1009
N06AX26
ATC
vortioxetine; oral
1.8
10.2
164
913
L12.0
ICD-10 Finland
Bullous pemphigoid
4.5
10.2
35
79
M01AX01
ATC
nabumetone; oral
1.8
10.1
178
1021
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
10.1
1384
11784
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.3
10.1
86
371
M01AH01
ATC
celecoxib; oral (coxibs)
1.3
10.0
731
5725
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
10.0
600
4559
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
10.0
390
2737
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.5
10.0
305
2031
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.4
10.0
427
3057
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
10.0
1065
8795
R42
ICD-10 Finland
Dizziness and giddiness
1.3
10.0
840
6722
L57.8
ICD-10 Finland
Other skin changes due to chronic exposure to nonionizing radiation
6.1
10.0
26
43
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.8
9.9
174
999
M01AX05
ATC
glucosamine; oral
1.3
9.9
875
7052
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.4
9.8
609
4656
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.7
9.8
184
1078
K05.12
ICD-10 Finland
Gingivitis (chronic) simple marginal
10.6
9.8
18
17
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
9.7
410
2925
D07XB05
ATC
dexamethasone, combinations; topical
2.1
9.7
104
497
XKD00
NOMESCO Finland
Uroflowmetry
1.4
9.7
472
3459
K30
ICD-10 Finland
Functional dyspepsia
1.5
9.7
382
2687
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.6
9.7
260
1681
D07CB01
ATC
triamcinolone and antibiotics; topical
2.3
9.6
83
360
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.5
9.6
334
2288
VALMI
NOMESCO Finland
NA
1.3
9.6
835
6703
N76.0
ICD-10 Finland
Acute vaginitis
1.9
9.6
144
785
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.5
9.6
345
2387
K11.70
ICD-10 Finland
Hypoptyalism
3.8
9.6
39
104
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
9.5
759
6020
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.5
9.5
295
1974
SGA01
NOMESCO Finland
Tooth opening as first aid
1.4
9.5
503
3744
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
9.5
955
7821
M45
ICD-10 Finland
Ankylosing spondylitis
2.4
9.5
75
311
SPAT1097
SPAT
Recording of ECG
1.4
9.5
586
4476
L20.8
ICD-10 Finland
Other atopic dermatitis
3.4
9.4
44
131
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
9.4
998
8223
8070/3-C03.1
ICD-O-3
Squamous cell carcinoma, NOS, of lower gum
30.1
9.4
12
*
L41.1
ICD-10 Finland
Pityriasis lichenoides chronica
30.1
9.4
12
*
L44.2
ICD-10 Finland
Lichen striatus
+∞
9.4
9
*
6961A
ICD-9 Finland
Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]
+∞
9.4
9
*
LEA10
NOMESCO Finland
Colpotomy
21.7
9.3
13
6
ECA30
NOMESCO Finland
Excision of lesion of gingiva
3.1
9.2
49
161
104
Kela drug reimbursment
Thyroid insufficiency
1.5
9.2
306
2080
N06AX16
ATC
venlafaxine; oral
1.4
9.2
471
3485
M79.1
ICD-10 Finland
Myalgia
1.4
9.2
451
3310
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.5
9.2
310
2115
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
9.1
1617
14118
R09
ICPC
Sinus symptom/complaint
1.6
9.1
253
1650
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
2.2
9.1
87
396
G03CA04
ATC
estriol; systemic, vaginal
1.5
9.1
309
2108
J05AB11
ATC
valaciclovir; oral
1.4
9.1
475
3523
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
9.0
344
2404
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
9.0
1058
8823
G04CA02
ATC
tamsulosin; oral
1.3
9.0
625
4857
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
9.0
701
5541
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.3
8.9
791
6365
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
2.9
8.9
52
182
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.6
8.8
254
1669
EBB10
NOMESCO Finland
Insertion of dental implant
2.7
8.8
60
228
R03BA08
ATC
ciclesonide; inhalant
1.5
8.8
295
2007
P03
ICPC
Feeling depressed
1.6
8.8
246
1609
C10AX09
ATC
ezetimibe; oral
1.4
8.8
417
3044
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
8.7
695
5510
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
3.2
8.7
44
140
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
8.7
385
2772
K08.80
ICD-10 Finland
Toothache NOS
1.6
8.7
249
1636
K60.2
ICD-10 Finland
Anal fissure, unspecified
2.5
8.7
63
250
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.1
8.7
94
454
L71.8
ICD-10 Finland
Other rosacea
2.6
8.7
59
225
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.0
8.6
112
581
S06
ICPC
Rash localized
1.6
8.6
200
1243
N05CF01
ATC
zopiclone; oral
1.2
8.6
1266
10821
L13
ICPC
Hip symptom/complaint
1.3
8.5
630
4939
K02.0
ICD-10 Finland
Caries limited to enamel
1.4
8.5
395
2870
A04
ICPC
Weakness/tiredness general
1.4
8.5
437
3235
N76.8
ICD-10 Finland
Other specified inflammation of vagina and vulva
3.0
8.4
45
149
K14.61
ICD-10 Finland
Glossodynia
3.2
8.4
41
127
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
1.5
8.4
279
1894
L42
ICD-10 Finland
Pityriasis rosea
5.6
8.4
23
41
377
Kela drug reimbursment
Apremilast and dimethyl fumarate (psoriasis)
90.2
8.4
9
*
SPAT1081
SPAT
Cardiorespiratory global assessment
1.6
8.4
215
1376
M54.6
ICD-10 Finland
Pain in thoracic spine
1.6
8.3
232
1516
R05FB02
ATC
cough suppressants and expectorants
1.2
8.3
1505
13137
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
8.3
629
4947
L40.2
ICD-10 Finland
Acrodermatitis continua
+∞
8.3
8
*
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.7
8.3
177
1075
D11
ICPC
Diarrhoea
1.4
8.3
347
2475
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.7
8.3
165
987
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
4.3
8.3
29
68
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
8.3
667
5295
K50.8
ICD-10 Finland
Other Crohn disease
2.6
8.3
57
220
WX704
NOMESCO Finland
Intubation
1.5
8.2
250
1664
A03
ICPC
Fever
1.4
8.2
473
3569
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
2.7
8.2
54
205
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
8.1
403
2962
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
8.1
1345
11628
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
1.7
8.1
170
1030
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.5
8.1
300
2088
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
2.4
8.1
67
287
ZXA05
NOMESCO Finland
Left side
1.2
8.1
985
8240
H60.8
ICD-10 Finland
Other otitis externa
2.0
8.1
94
468
M13.9
ICD-10 Finland
Arthritis, unspecified
1.5
8.1
242
1607
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
10.0
8.0
15
15
N94.1
ICD-10 Finland
Dyspareunia
3.6
8.0
34
95
R03AC03
ATC
terbutaline; inhalant
1.3
8.0
510
3910
WX720
NOMESCO Finland
Own respiration
1.8
8.0
137
783
R06AX13
ATC
loratadine; oral
1.3
8.0
523
4030
L01
ICPC
Neck symptom/complaint
1.3
7.9
483
3679
WKPAL
NOMESCO Finland
NA
2.2
7.9
74
338
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.4
7.8
446
3358
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
2.3
7.8
67
289
K03.66
ICD-10 Finland
Tooth plaque
1.6
7.8
211
1369
ZXC10
NOMESCO Finland
Use of laser
2.1
7.8
83
400
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.6
7.8
216
1410
A05AA02
ATC
ursodeoxycholic acid; oral
2.5
7.8
57
227
F41.00
ICD-10 Finland
Moderate panic disorder
2.7
7.7
48
176
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.7
7.7
142
828
S88
ICPC
Dermatitis contact/allergic
2.2
7.7
73
334
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.6
7.7
171
1053
J01CA08
ATC
pivmecillinam; oral
1.2
7.7
1593
14062
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
7.7
436
3280
A02BC04
ATC
rabeprazole; oral
1.4
7.7
310
2197
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
7.7
363
2648
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
7.7
972
8157
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
7.6
444
3353
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
7.6
180
1128
L50.9
ICD-10 Finland
Urticaria, unspecified
1.8
7.6
121
677
R52.2
ICD-10 Finland
Other chronic pain
1.8
7.6
119
662
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.4
7.5
59
244
EJB40
NOMESCO Finland
Hemiglossectomy
8.8
7.5
15
17
L04AC10
ATC
secukinumab; parenteral
10.0
7.5
14
14
EAA30
NOMESCO Finland
Partial excision of lower lip
10.0
7.5
14
14
S87
ICPC
Dermatitis/atopic eczema
2.2
7.5
75
350
J45
ICD-10 Finland
Asthma
1.4
7.4
333
2407
R60.0
ICD-10 Finland
Localized oedema
1.4
7.4
385
2854
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
1.8
7.4
129
743
D02
ICPC
Abdominal pain epigastric
1.6
7.4
197
1275
N51.8*A60.0
ICD-10 Finland
Herpes simplex infection of the genitals in men
13.4
7.4
12
9
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.5
7.4
212
1399
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.6
7.4
176
1110
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.5
7.4
216
1429
L30
ICD-10 Finland
Other dermatitis
2.2
7.3
69
313
A03FA02
ATC
cisapride; oral, rectal
1.4
7.3
294
2083
M07.0*L40.5
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
+∞
7.3
7
*
L41.8
ICD-10 Finland
Other parapsoriasis
+∞
7.3
7
*
L02
ICPC
Back symptom/complaint
1.4
7.3
299
2125
J01FA15
ATC
telithromycin; oral
1.4
7.3
356
2613
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
7.3
258
1782
Z00.0
ICD-10 Finland
General medical examination
1.3
7.3
638
5118
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
2.1
7.3
81
396
K50.1
ICD-10 Finland
Crohn disease of large intestine
2.7
7.2
47
177
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.4
7.2
291
2062
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.3
7.2
549
4321
J01MA06
ATC
norfloxacin; oral
1.3
7.2
503
3908
L28.2
ICD-10 Finland
Other prurigo
4.3
7.2
25
59
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.4
7.2
289
2049
R21
ICPC
Throat symptom/complaint
1.3
7.2
574
4550
N04BC05
ATC
pramipexole; oral
1.5
7.1
265
1849
L12
ICPC
Hand/finger symptom/complaint
1.3
7.1
482
3729
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.5
7.1
221
1481
QXA70
NOMESCO Finland
Guidance related to rash and skin care
20.0
7.1
10
5
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.3
7.1
489
3792
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.3
7.1
451
3458
G03CC04
ATC
estrone; systemic
1.7
7.1
138
821
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
7.1
257
1783
L04AB01
ATC
etanercept; parenteral
2.7
7.1
46
173
S02CA02
ATC
flumetasone and antiinfectives; otic
1.5
7.1
198
1299
D01AE15
ATC
terbinafine; topical
1.5
7.1
238
1625
B03BA03
ATC
hydroxocobalamin; parenteral
1.6
7.1
193
1257
N05BA04
ATC
oxazepam; oral
1.2
7.1
902
7568
K13
ICD-10 Finland
Other diseases of lip and oral mucosa
5.6
7.0
19
34
D11AH01
ATC
tacrolimus; topical
3.6
7.0
29
80
K11.2
ICD-10 Finland
Sialoadenitis
1.8
7.0
107
592
Z01.9
ICD-10 Finland
Special examination, unspecified
1.6
7.0
194
1267
R49.08
ICD-10 Finland
Other specified dysphonia
2.1
7.0
75
363
R02
ICPC
Shortness of breath/dyspnoea
1.3
7.0
422
3211
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
6.9
2349
21605
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
6.9
229
1557
F29
ICPC
Eye symptom/complaint other
1.4
6.9
282
2004
N06AB04
ATC
citalopram; systemic
1.3
6.9
782
6472
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
3.4
6.9
31
92
L28
ICPC
Limited function/disability (L)
1.3
6.9
568
4518
UDC00
NOMESCO Finland
Ear microscopy
1.5
6.9
243
1677
H01
ICPC
Ear pain/earache
1.4
6.9
329
2408
L29.8
ICD-10 Finland
Other pruritus
2.6
6.9
45
171
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.4
6.9
281
2000
ZXC50
NOMESCO Finland
Cryotherapy
1.8
6.9
103
565
N81.6
ICD-10 Finland
Rectocele
1.4
6.8
275
1950
L12.9
ICD-10 Finland
Pemphigoid, unspecified
8.3
6.8
14
17
P76
ICPC
Depressive disorder
1.6
6.8
170
1085
L04AA01
ATC
[U] ciclosporin; systemic
2.3
6.8
58
254
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
2.5
6.8
48
190
EKC00
NOMESCO Finland
Suture of cheek
9.3
6.8
13
14
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.4
6.8
274
1941
K60.1
ICD-10 Finland
Chronic anal fissure
2.0
6.7
82
420
L73.9
ICD-10 Finland
Follicular disorder, unspecified
4.7
6.7
21
45
R44
ICPC
Respiratory, Preventive immunization/medic
2.2
6.7
60
269
QBA
NOMESCO Finland
Incision or local destruction of lesion of skin of trunk
22.5
6.7
9
*
D83
ICPC
Mouth/tongue/lip disease
3.6
6.7
28
79
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.4
6.6
368
2761
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
1.6
6.6
170
1092
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
2.5
6.6
47
186
C10AC01
ATC
colestyramine; oral
1.9
6.6
96
523
ZX198
NOMESCO Finland
Other local administration
2.6
6.6
44
169
B37.0
ICD-10 Finland
Candidal stomatitis
2.6
6.6
45
176
L71.9
ICD-10 Finland
Rosacea, unspecified
2.0
6.6
76
377
SPAT1043
SPAT
Audiometry
1.4
6.6
376
2835
K12.1
ICD-10 Finland
Other forms of stomatitis
12.2
6.6
11
9
K04.1
ICD-10 Finland
Necrosis of pulp
1.4
6.5
335
2482
N01
ICPC
Headache
1.4
6.5
286
2060
R5140
NOMESCO Finland
Monitoring the use of the aid
1.4
6.5
341
2534
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.0
6.5
74
369
L04AA13
ATC
leflunomide; oral
1.9
6.5
90
480
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.5
6.5
182
1194
A10AE04
ATC
insulin glargine; parenteral
1.4
6.5
295
2140
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
3.5
6.5
28
81
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.4
6.5
280
2014
N06AB10
ATC
escitalopram; oral
1.3
6.5
637
5182
F45.8
ICD-10 Finland
Other somatoform disorders
1.5
6.5
185
1222
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
1.9
6.5
82
426
L56.8
ICD-10 Finland
Other specified acute skin changes due to ultraviolet radiation
7.4
6.4
14
19
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.5
6.4
199
1336
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
14.3
6.4
10
7
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
4.7
6.4
20
43
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.4
6.4
340
2533
J04BA02
ATC
dapsone; oral
3.5
6.4
27
77
XKC03
NOMESCO Finland
Water cystometry
1.7
6.3
115
671
J01DB05
ATC
cefadroxil; oral
1.6
6.3
139
859
K29.4
ICD-10 Finland
Chronic atrophic gastritis
1.9
6.3
81
424
L12.8
ICD-10 Finland
Other pemphigoid
11.0
6.3
11
10
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.3
6.3
507
4022
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
1.6
6.3
169
1101
Z50.1
ICD-10 Finland
Other physical therapy
1.5
6.3
187
1244
B86
ICD-10 Finland
Scabies
2.5
6.3
46
188
Z97.4
ICD-10 Finland
Presence of external hearing-aid
1.6
6.3
145
908
P01
ICPC
Feeling anxious/nervous/tense
1.4
6.3
238
1669
L04AA32
ATC
apremilast; oral
+∞
6.2
6
*
WQ054
NOMESCO Finland
NA
+∞
6.2
6
*
69619
ICD-8 Finland
Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)
+∞
6.2
6
*
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.3
6.2
621
5060
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
6.2
827
6959
M79.7
ICD-10 Finland
Fibromyalgia
1.7
6.2
116
682
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.5
6.2
232
1623
N30.9
ICD-10 Finland
Cystitis, unspecified
1.5
6.2
188
1255
L23.8
ICD-10 Finland
Allergic contact dermatitis due to other agents
3.3
6.2
28
84
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
7.0
6.2
14
20
T78.3
ICD-10 Finland
Angioneurotic oedema
2.3
6.2
51
220
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.3
6.2
673
5541
Y29
ICPC
Genital symptom/complaint male other
4.1
6.2
22
54
TNG10
NOMESCO Finland
Puncture of knee
2.6
6.2
41
158
K07
ICPC
Swollen ankles/oedema
1.6
6.2
149
944
H29
ICPC
Ear symptom/complaint other
1.4
6.2
346
2600
N89.8
ICD-10 Finland
Other specified noninflammatory disorders of vagina
3.8
6.2
24
64
B35.1
ICD-10 Finland
Tinea unguium
1.5
6.2
183
1220
L71.0
ICD-10 Finland
Perioral dermatitis
2.4
6.1
47
194
N17
ICPC
Vertigo/dizziness
1.3
6.1
396
3045
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.6
6.1
137
849
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
6.1
526
4209
WX725
NOMESCO Finland
Noninvasive ventilation
1.6
6.1
155
996
C10AA05
ATC
atorvastatin; oral
1.2
6.1
1457
12968
TQW99
NOMESCO Finland
Other minor procedure on skin
1.6
6.1
167
1089
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
1.3
6.1
384
2941
J33.0
ICD-10 Finland
Polyp of nasal cavity
1.9
6.1
87
471
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
1.8
6.1
99
562
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
1.9
6.1
75
388
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.4
6.0
330
2473
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
1.5
6.0
225
1573
K07.23
ICD-10 Finland
Deep bite
2.2
6.0
55
249
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768443) Skin Pathology biopsy report
704
1882
4.18
235.32
1.3
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
349
587
6.31
199.66
2.2
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
970
5080
2.12
87.07
1.7
1.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
167
316
5.43
83.85
1.5
1.5
u/ml
20.1
20.6
0.04
43
70
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
142
279
5.21
68.35
1.3
1.4
titre
350.0
456.5
—
9
26
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
140
273
5.24
67.96
1.3
1.4
titre
56.5
61.1
0.09
17
27
(3013707) Erythrocyte sedimentation rate by Westergren method
3831
32400
1.74
60.42
5.0
4.1
mm/h
12.6
13.0
0.91
3561
29809
(3006315) Basophils [#/volume] in Blood
2693
21223
1.57
52.77
6.6
5.6
e9/l
0.0
0.0
1.77
2392
18121
(3013115) Eosinophils [#/volume] in Blood
2769
21969
1.57
52.62
6.8
5.8
e9/l
0.2
0.2
3.40
2473
19070
(3037522) Nuclear Ab [Titer] in Serum
928
5591
1.81
52.43
1.4
1.3
titre
589.4
541.9
0.28
203
1250
(3001604) Monocytes [#/volume] in Blood
2668
21118
1.55
50.25
6.6
5.6
e9/l
0.6
0.6
1.02
2371
18021
(3019198) Lymphocytes [#/volume] in Blood
2721
21676
1.55
49.45
6.6
5.6
e9/l
1.9
1.9
0.80
2425
18885
(40768804) Tissue Pathology biopsy report
2338
18129
1.54
47.25
2.4
2.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1323
9096
1.61
44.89
1.3
1.2
u/ml
1.4
1.7
0.45
374
2355
(3013650) Neutrophils [#/volume] in Blood by Automated count
3004
24871
1.51
42.56
9.3
9.0
e9/l
3.9
4.1
4.62
2685
21554
(3037467) Urinalysis macro (dipstick) panel - Urine
3478
29735
1.53
42.00
5.3
4.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3876
34059
1.58
40.28
8.3
7.6
u/l
78.2
78.9
0.37
3667
31958
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3828
33659
1.55
38.48
4.9
4.2
pmol/l
14.9
14.9
0.00
3470
30385
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4378
39841
1.70
37.22
6.0
5.0
mu/l
1.9
2.1
1.04
4019
36225
(3006504) Eosinophils/100 leukocytes in Blood
2443
19797
1.45
35.87
7.0
5.8
%
3.1
2.8
4.42
2282
18313
(3022096) Basophils/100 leukocytes in Blood
2382
19225
1.45
35.65
7.0
5.9
%
0.7
0.7
2.46
2227
17793
(3007853) Bacteria identified in Skin by Aerobe culture
775
4902
1.69
35.59
1.8
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
2468
20063
1.45
35.47
6.8
5.7
%
56.8
57.3
1.20
2299
18614
(3019069) Monocytes/100 leukocytes in Blood
2452
19909
1.45
35.47
7.3
6.1
%
8.6
8.7
0.07
2294
18500
(3002030) Lymphocytes/100 leukocytes in Blood
2493
20368
1.44
34.50
7.1
5.9
%
28.0
27.8
0.43
2317
18808
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
54
82
6.65
33.96
2.0
1.5
ug/l
9.3
9.1
0.14
54
82
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1802
13903
1.46
33.66
2.7
2.6
u/l
55.6
57.9
1.34
1651
12774
(3031040) Bacteria [#/volume] in Urine by Automated count
3331
28778
1.45
33.63
5.4
4.7
e6/l
79.8
2178.7
6.27
34
406
(3007164) IgA [Mass/volume] in Serum or Plasma
1123
7884
1.54
33.24
1.5
1.5
g/l
2.5
2.5
0.29
688
4617
(3048689) Calprotectin [Mass/mass] in Stool
772
4969
1.65
32.95
2.5
2.1
ug/g
153.2
142.9
0.31
612
3845
(3015171) Extractable nuclear Ab [Units/volume] in Serum
328
1629
2.08
32.31
1.3
1.2
u/ml
2.2
1.0
0.47
24
163
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4604
42816
1.78
32.00
16.8
14.6
mg/l
21.5
23.8
4.87
3781
33955
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2272
18547
1.41
29.98
2.1
2.0
pmol/l
95.5
96.5
0.42
1142
9161
(3035350) Ketones [Presence] in Urine by Test strip
2521
20954
1.40
29.92
4.4
3.8
estimate
0.0
0.0
0.00
412
3791
(3024561) Albumin [Mass/volume] in Serum or Plasma
2357
19401
1.40
29.44
5.1
4.7
g/l
35.6
35.4
1.29
2205
17967
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1052
7451
1.52
29.41
1.3
1.3
iu/ml
33.5
35.7
0.24
340
2365
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2740
23145
1.40
29.31
6.0
6.3
umol/l
11.0
11.2
0.48
2587
21921
(42870588) Differential panel, method unspecified - Blood
1840
14542
1.42
28.95
6.8
5.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1242
9137
1.48
28.74
4.7
4.3
kg/l
1.0
1.0
0.06
193
1366
(3021601) Nitrite [Presence] in Urine by Test strip
2520
21045
1.39
28.53
6.0
5.1
estimate
0.0
0.0
0.80
417
3837
(3009261) Glucose [Presence] in Urine by Test strip
2538
21306
1.38
27.38
4.5
3.8
estimate
0.0
0.0
1.57
398
3787
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
990
7027
1.51
27.13
1.3
1.3
u/ml
16.4
14.0
0.22
388
2667
(3019550) Sodium [Moles/volume] in Serum or Plasma
4741
44792
1.84
26.89
18.9
16.9
mmol/l
139.7
139.7
0.61
4638
43689
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1733
13689
1.40
26.81
2.2
2.1
u/l
158.0
199.9
2.23
1609
12776
(3023103) Potassium [Moles/volume] in Serum or Plasma
4748
44912
1.84
26.34
19.0
17.1
mmol/l
4.0
4.0
0.29
4641
43735
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2667
22694
1.37
25.78
6.4
6.7
mmol/l
1.2
1.2
1.10
2262
19100
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2251
18659
1.37
25.62
2.4
2.2
nmol/l
78.3
79.3
0.92
2008
16615
(3026008) Bacteria identified in Urine by Culture
1761
14088
1.38
24.74
3.7
3.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
2968
25785
1.36
24.58
4.7
4.6
mmol/l
6.7
6.7
0.03
2798
24182
(3005322) IgE [Units/volume] in Serum or Plasma
419
2489
1.74
23.75
1.3
1.3
u/ml
311.8
188.3
1.32
386
2284
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
959
6943
1.47
23.43
1.5
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4795
45735
1.82
22.42
12.9
10.6
u/l
25.9
25.7
0.19
4646
43975
(4010399)
505
3230
1.63
21.60
1.5
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1331
10354
1.39
21.53
1.6
1.5
nmol/l
21.4
20.9
0.54
1146
8751
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1939
16003
1.34
21.44
4.8
4.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
243
1261
1.97
21.17
1.6
1.5
g/l
1.2
1.2
0.14
232
1194
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
237
1222
1.99
21.03
1.6
1.6
g/l
0.2
0.2
0.26
226
1158
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4498
42318
1.54
20.96
5.3
4.8
mmol/l
6.0
6.0
1.37
4121
38329
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4320
40349
1.46
20.47
6.7
5.9
mmol/mol
40.3
39.9
1.54
4003
37090
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
108
403
2.72
20.42
1.3
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1170
8992
1.39
20.14
5.0
4.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
381
2307
1.70
20.10
1.3
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4529
42750
1.53
19.94
5.3
4.6
mmol/l
4.7
4.7
4.82
4202
39249
(40768797) Stomach Pathology biopsy report
859
6298
1.44
19.25
1.3
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1692
13852
1.33
19.19
3.5
3.2
u/l
34.6
35.6
0.15
1595
13099
(3011397) Hemoglobin [Presence] in Urine by Test strip
1291
10161
1.36
19.00
4.4
3.8
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
4772
45709
1.69
18.48
19.8
17.1
umol/l
76.3
76.3
0.00
4767
45696
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1356
10794
1.35
18.44
2.4
2.3
mg/l
2.9
3.0
1.24
1160
9201
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4598
43660
1.54
18.40
5.7
5.1
mmol/l
2.7
2.8
3.05
4232
39886
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1607
13147
1.32
18.05
3.0
3.0
ng/l
1110.4
1355.2
2.17
1375
11292
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
223
1190
1.91
17.92
1.3
1.3
u/ml
8.7
42.1
—
9
74
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2066
17537
1.30
17.60
3.0
2.8
ug/l
131.0
136.0
0.35
1883
16086
(3032080) INR in Blood by Coagulation assay
2110
17982
1.30
17.36
9.4
9.1
inr
1.2
1.3
0.23
563
5047
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4483
42431
1.47
17.32
5.1
4.5
mmol/l
1.5
1.5
3.88
4127
38713
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1994
16874
1.30
17.29
4.0
3.7
ng/l
69.0
73.6
0.04
1376
11829
(3000570) Elastase.pancreatic [Mass/mass] in Stool
247
1384
1.82
17.05
1.4
1.4
ug/g
269.4
277.8
0.27
146
820
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
487
3263
1.54
16.95
1.7
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
781
5751
1.42
16.90
7.7
6.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
4889
47289
1.84
16.38
25.5
21.6
e9/l
249.4
251.9
1.96
4775
46038
(3042936) Bacteria identified in Isolate by Culture
815
6078
1.41
16.37
2.1
2.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
4890
47305
1.84
16.33
25.4
21.5
fl
91.3
91.2
0.02
4821
46585
(3036481) Cortisol [Moles/volume] in Serum or Plasma
556
3865
1.49
16.25
2.4
2.2
nmol/l
364.9
375.5
0.62
499
3542
(3026361) Erythrocytes [#/volume] in Blood
4890
47311
1.83
16.23
25.5
21.6
e12/l
4.5
4.5
1.10
4765
45896
(3019309) Folate [Moles/volume] in Red Blood Cells
1081
8452
1.35
16.22
1.7
1.8
nmol/l
1135.0
1173.3
0.73
815
6353
(40761535) Cells panel - Urine sediment
533
3679
1.50
16.12
3.8
3.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
4890
47322
1.83
16.06
25.6
21.7
g/l
134.8
134.2
2.31
4822
46610
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4340
40949
1.40
15.96
4.6
4.0
mmol/l
1.3
1.3
1.11
3975
37012
(3010813) Leukocytes [#/volume] in Blood
4889
47317
1.82
15.94
25.5
21.6
e9/l
6.6
6.7
0.45
4759
45901
(3035941) MCH [Entitic mass]
4888
47306
1.82
15.92
25.4
21.5
pg
30.4
30.3
0.87
4820
46583
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2739
24319
1.27
15.60
2.8
2.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
566
3980
1.47
15.59
1.5
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1388
11317
1.31
15.47
4.9
4.3
estimate
0.0
0.0
0.04
407
3724
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2366
20671
1.27
15.26
5.4
5.9
mmol/l
1.2
1.2
0.73
2116
18627
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
173
901
1.95
14.99
1.3
1.2
u/ml
7.0
3.2
0.44
17
65
(36660697) Celiac disease serology panel - Serum
484
3325
1.50
14.95
1.2
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
165
853
1.97
14.61
1.3
1.2
u/ml
39.9
44.7
0.16
21
104
(3020961) Endomysium IgA Ab [Titer] in Serum
298
1845
1.65
14.44
1.1
1.1
titre
169.5
195.1
0.09
11
41
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2338
20499
1.26
14.27
4.3
4.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
198
1105
1.82
13.89
1.3
1.3
u/ml
2.7
6.9
2.02
36
192
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3037
27508
1.26
13.74
3.5
3.1
u/l
49.2
49.3
0.03
2813
25359
(3005719) IgG [Mass/volume] in Serum or Plasma
455
3142
1.49
13.68
2.6
2.8
g/l
10.6
10.4
0.53
424
2861
(3012516) Albumin [Mass/volume] in Urine
1581
13289
1.28
13.56
3.4
3.2
mg/l
699.4
351.6
1.37
953
8117
(3013139) Helicobacter pylori Ag [Presence] in Stool
437
3003
1.50
13.45
1.3
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1650
13978
1.27
13.18
4.1
3.9
mg/mmol
9.3
8.9
0.14
996
8531
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
220
1294
1.73
12.93
1.7
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
193
1093
1.80
12.92
1.3
1.3
u/ml
5.8
5.1
0.08
23
119
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1171
9528
1.30
12.86
1.7
1.7
mg/l
1.2
1.3
0.53
895
7324
(3009508) Creatinine [Moles/volume] in Urine
1625
13825
1.26
12.32
3.3
3.1
mmol/l
6.9
7.1
1.17
1368
11517
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
533
3871
1.42
12.27
2.8
2.9
ng/l
173.0
189.6
0.47
493
3537
(3023420) DNA double strand Ab [Units/volume] in Serum
93
414
2.27
12.23
1.4
1.4
iu/ml
17.8
22.7
—
5
20
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
195
1140
1.74
11.74
1.6
1.6
iu/ml
0.4
6.2
0.64
34
252
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
391
2701
1.48
11.72
1.2
1.2
iu/ml
109.8
148.8
1.51
148
1015
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1072
8721
1.29
11.63
4.0
3.7
ng/l
423.0
474.9
0.12
792
6944
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
895
7111
1.31
11.59
1.8
1.8
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
283
1830
1.58
11.51
5.2
5.6
%
0.9
0.9
0.37
267
1704
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
284
1840
1.58
11.46
5.2
5.5
%
1.7
1.6
0.26
268
1708
(40761511) CBC panel - Blood by Automated count
4616
44454
1.41
11.23
16.5
13.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
359
2478
1.48
10.81
1.6
1.9
g/l
1.3
1.4
0.38
325
2249
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1159
9601
1.27
10.76
1.7
1.7
pmol/l
77930746.1
32517571.5
1.03
947
7882
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
781
6147
1.32
10.76
1.5
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1340
11292
1.25
10.74
2.8
2.6
umol/l
3036.4
5032.3
1.38
1154
9699
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
518
3852
1.38
10.35
2.2
2.3
ug/l
5.9
6.9
0.67
436
3344
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
359
2509
1.46
10.15
2.6
2.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
747
5896
1.31
10.04
22.6
24.7
inr
1.3
1.3
0.17
135
841
(3008152) Bicarbonate [Moles/volume] in Arterial blood
394
2812
1.43
9.97
6.0
7.1
mmol/l
24.3
24.7
1.32
367
2610
(3025130) Human papilloma virus identified in Specimen
100
498
2.03
9.97
1.8
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
3338
31066
1.22
9.62
4.3
3.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
481
3584
1.38
9.49
4.1
3.9
%
1.0
0.9
0.11
116
1041
(3004588) Protein electrophoresis panel - Serum or Plasma
428
3130
1.40
9.44
2.3
2.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
41
139
2.97
9.44
1.8
1.7
—
—
—
0
0
(3013512) EKG study
1534
13275
1.22
9.36
4.7
4.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
555
4241
1.35
9.32
2.1
2.2
g/l
0.2
0.2
0.21
515
3959
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
592
4574
1.33
9.22
1.5
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
664
5230
1.31
9.02
1.7
1.7
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
98
505
1.96
8.92
1.3
1.3
u/ml
51.1
45.9
0.09
11
32
(3019060) Gas panel - Arterial blood
406
2977
1.40
8.82
4.4
5.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
205
1314
1.58
8.73
1.7
1.7
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3751
35448
1.22
8.68
22.3
19.0
g/l
332.2
331.6
3.59
3724
35184
(3025159) Blasts/100 leukocytes in Blood
428
3177
1.38
8.64
4.1
4.0
%
0.0
0.4
1.48
93
804
(3002179) Metamyelocytes/100 leukocytes in Blood
437
3264
1.37
8.49
3.9
3.8
%
0.8
0.6
0.51
83
742
(3021440) Promyelocytes/100 leukocytes in Blood
453
3406
1.36
8.44
4.2
4.0
%
0.1
0.2
0.59
110
959
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
179
1125
1.61
8.29
1.1
1.1
u/ml
8.5
8.9
0.03
17
106
(3004789) Transferrin [Mass/volume] in Serum or Plasma
769
6246
1.27
8.20
2.6
2.5
g/l
2.3
2.3
0.39
707
5763
(3022948) Iron [Moles/volume] in Serum or Plasma
827
6776
1.26
8.20
2.6
2.5
umol/l
13.0
12.8
0.21
765
6272
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
312
2216
1.43
8.13
1.9
1.8
—
—
—
0
0
(4062490)
80
399
2.02
8.02
1.9
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
2087
18799
1.19
7.94
10.8
9.5
e9/l
0.0
0.0
0.06
1758
15243
(3000850) Epithelial cells [#/volume] in Urine
1071
9071
1.23
7.84
2.7
2.6
e6/l
4.6
6.1
4.32
923
7911
(3018418) pH of Serum or Plasma
1550
13613
1.20
7.81
3.7
4.1
ph
7.4
7.4
0.10
253
2570
(40758558) Short blood count panel - Blood
1280
11053
1.21
7.71
7.0
6.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
341
2488
1.40
7.65
2.0
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1752
15594
1.19
7.54
3.3
3.4
mmol/l
2.4
2.4
0.32
1503
13448
(3007566) Smooth muscle Ab [Titer] in Serum
180
1161
1.57
7.51
1.2
1.2
titre
115.3
147.6
0.21
19
91
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
230
1565
1.49
7.51
1.5
1.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
214
1436
1.51
7.47
1.6
1.6
titre
493.3
309.7
—
9
70
(3018095) Leukocytes [#/volume] in Urine
1709
15191
1.19
7.45
4.2
3.7
e6/l
94.4
116.3
0.54
1259
10637
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
617
4938
1.28
7.38
3.7
4.3
u/l
234.6
247.9
1.98
569
4654
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
613
4905
1.28
7.34
1.8
1.8
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
360
2670
1.37
7.32
1.3
1.3
au/ml
52.0
49.7
—
7
121
(3047181) Lactate [Moles/volume] in Blood
211
1421
1.51
7.25
5.7
6.6
mmol/l
1.4
1.3
0.37
190
1245
(3023368) Bacteria identified in Blood by Culture
1351
11785
1.20
7.23
4.2
4.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
481
3737
1.32
7.19
2.5
2.6
g/l
67.2
66.2
1.99
435
3387
(1761482) Bacteria [#/volume] in Urine by Culture
170
1095
1.57
7.16
5.8
4.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
613
4921
1.28
7.15
1.8
1.7
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
178
1159
1.56
7.15
1.2
1.2
titre
865.0
1167.4
—
10
38
(44813793)
60
281
2.15
7.14
1.1
1.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
78
403
1.95
7.13
1.9
1.3
g/l
0.3
0.4
1.68
62
281
(3028192) IgG subclass 2 [Mass/volume] in Serum
78
403
1.95
7.13
1.9
1.3
g/l
2.9
2.8
0.21
59
282
(3030981) Hyaline casts [#/volume] in Urine by Automated count
298
2159
1.40
6.99
2.9
2.7
e6/l
0.2
0.3
0.74
290
2104
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
214
1458
1.49
6.96
1.4
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
883
7422
1.23
6.87
2.9
2.7
e6/l
0.8
1.2
4.00
551
4183
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
27
87
3.11
6.85
1.9
1.9
mg/l
8.1
9.1
0.43
21
72
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1238
10762
1.20
6.82
5.0
4.9
ug/l
2.2
2.9
1.27
1105
9634
(3027135) IgG subclass 1 [Mass/volume] in Serum
77
403
1.92
6.80
1.9
1.3
g/l
6.4
6.9
0.70
60
279
(3022145) Colonoscopy Study observation
616
4979
1.27
6.79
1.4
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
710
5837
1.25
6.77
2.7
2.6
%
22.3
22.3
0.01
568
4951
(3004616) Nuclear Ab [Presence] in Serum
99
563
1.77
6.73
1.3
1.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
47
204
2.32
6.73
1.1
1.4
umol/l
19.0
24.2
0.64
47
192
(3009542) Hematocrit [Volume Fraction] of Blood
3989
38212
1.20
6.65
18.2
15.8
%
39.5
39.4
0.26
2517
26363
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1366
12002
1.19
6.65
1.8
1.6
mmol/l
1.4
1.4
0.11
1161
9979
(3026782) Osmolality of Urine
980
8353
1.21
6.63
3.1
2.7
mosm/kgh2o
529.0
532.7
0.21
823
7067
(3030467) Casts [#/volume] in Urine by Automated count
1363
11992
1.19
6.51
3.4
3.1
e6/l
0.3
0.5
6.34
1053
8947
(3014765) Yersinia sp identified in Stool by Organism specific culture
185
1245
1.50
6.42
1.3
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
178
1191
1.51
6.35
1.1
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
467
3677
1.30
6.33
2.4
2.6
e9/l
68.5
70.1
0.43
362
2773
(3041096) Erythrocytes [Presence] in Urine by Automated
1259
11026
1.19
6.31
4.0
3.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
185
1252
1.50
6.26
1.3
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1461
12972
1.18
6.21
3.6
3.2
e6/l
43.0
77.7
2.26
1150
9843
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
383
2943
1.33
6.20
2.6
2.4
au/ml
35.4
24.5
—
8
139
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
182
1232
1.49
6.16
1.3
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
106
634
1.69
6.06
1.8
1.5
g/l
0.6
0.8
1.12
81
473
(3018572) Chloride [Moles/volume] in Blood
158
1044
1.53
6.00
6.5
7.5
mmol/l
104.9
105.1
0.14
144
927
(3039000) Anion gap in Blood
158
1044
1.53
6.00
6.5
7.5
mmol/l
11.4
11.2
0.31
144
927
(3027945) Reticulocytes/100 erythrocytes in Blood
595
4868
1.25
5.90
2.5
2.5
%
1.8
1.8
0.45
520
4323
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
108
656
1.66
5.84
1.2
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
56
278
2.03
5.80
1.8
2.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
556
4524
1.26
5.79
6.5
7.6
%
96.2
95.7
1.80
530
4345
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
280
2080
1.37
5.70
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
257
1893
1.38
5.52
1.3
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
148
983
1.52
5.52
1.9
1.7
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
17
47
3.63
5.47
1.0
1.0
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
69
376
1.85
5.46
1.2
1.2
u/ml
61.0
32.6
—
10
34
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
229
1658
1.40
5.46
2.8
2.3
g/l
9.7
10.1
0.67
183
1399
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
66
355
1.87
5.44
1.2
1.2
u/ml
2.4
3.4
—
5
25
(3017732) Neutrophils [#/volume] in Blood
379
2965
1.30
5.42
2.7
3.0
e9/l
4.0
4.1
0.26
284
2282
(3002173) Hemoglobin [Mass/volume] in Arterial blood
517
4208
1.25
5.37
6.9
8.0
g/l
120.9
120.5
0.14
495
4041
(3010144) Erythrocytes [#/volume] in Synovial fluid
74
416
1.79
5.31
1.5
1.3
e6/l
13182.3
95399.1
1.83
46
278
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
127
824
1.56
5.28
3.1
3.8
%
57.5
57.9
0.16
127
824
(3000330) Specific gravity of Urine by Test strip
295
2239
1.34
5.24
4.9
3.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
272
2045
1.35
5.15
4.0
3.2
mmol/l
25.3
25.3
0.01
266
1981
(3019225) pH of Specimen
575
4758
1.24
5.15
4.2
4.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
610
5088
1.23
5.06
6.4
7.1
kpa
5.1
5.1
0.41
573
4841
(3003396) Base excess in Arterial blood by calculation
609
5083
1.23
5.02
6.4
7.2
mmol/l
1.1
1.1
0.13
460
3979
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
345
2697
1.30
4.98
3.3
3.2
pmol/l
4.4
4.4
0.70
304
2375
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
442
3565
1.26
4.97
2.6
2.6
ml/min/173m2
62.4
64.2
0.52
193
1410
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
177
1246
1.44
4.97
2.0
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
300
2304
1.32
4.93
2.2
2.2
nmol/l
12.4
12.8
0.43
261
2029
(3027801) Oxygen [Partial pressure] in Arterial blood
608
5086
1.22
4.91
6.4
7.1
kpa
12.3
12.3
0.00
572
4838
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
57
306
1.87
4.78
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
57
306
1.87
4.78
1.2
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4213
40848
1.18
4.76
15.2
13.7
ml/min/173m2
78.4
78.3
0.16
3540
33730
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
57
307
1.87
4.73
1.2
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
675
5726
1.21
4.72
5.6
5.7
mmol/l
1.0
1.0
0.50
635
5295
(3022621) pH of Urine by Test strip
365
2897
1.28
4.70
3.4
3.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
141
965
1.47
4.61
2.4
2.1
g/l
130.5
127.6
0.66
100
684
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
57
310
1.85
4.60
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
57
310
1.85
4.60
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
57
310
1.85
4.60
1.2
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
151
1048
1.45
4.60
1.3
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
54
289
1.88
4.58
1.7
2.0
%
15.0
15.4
0.05
28
118
(3020779) Urea [Moles/volume] in Serum or Plasma
468
3839
1.24
4.55
6.8
7.3
mmol/l
9.3
9.9
1.13
440
3657
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
52
276
1.89
4.53
1.1
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
71
417
1.71
4.45
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
264
2023
1.32
4.44
2.0
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
235
1772
1.34
4.41
2.8
2.3
g/l
3.9
3.8
0.37
166
1289
(3012095) Magnesium [Moles/volume] in Serum or Plasma
838
7292
1.18
4.40
2.9
3.2
mmol/l
0.8
0.8
0.32
781
6773
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
592
4994
1.21
4.39
2.4
2.7
umol/l
7.5
8.3
0.51
517
4333
(3052592) Norovirus Ag [Presence] in Stool
23
88
2.62
4.39
1.1
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
235
1774
1.34
4.38
2.8
2.3
g/l
7.4
7.5
0.61
168
1348
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
52
280
1.87
4.35
1.1
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
234
1773
1.34
4.27
2.8
2.3
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
30
133
2.26
4.21
1.3
1.3
g/l
0.3
0.3
0.15
23
108
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
241
1839
1.33
4.19
2.3
1.9
u/l
40.2
39.6
0.17
209
1618
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
786
6831
1.18
4.18
3.2
2.9
e6/l
2.7
3.0
0.46
459
3615
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
161
1154
1.41
4.15
2.3
2.0
mg/l
10.3
11.6
1.38
145
1056
(36304419) Bacteria [Presence] in Urine
1290
11654
1.14
4.07
3.4
3.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
23
92
2.51
4.04
1.0
1.1
u/ml
2.5
0.8
—
9
43
(3017704) Immunofixation for Urine
46
246
1.88
3.96
1.9
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
65
386
1.69
3.95
1.7
2.3
e9/l
1.1
1.1
0.10
47
228
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
971
8616
1.16
3.95
4.5
4.2
%
21.1
21.8
0.68
431
4195
(3002385) Erythrocyte distribution width [Ratio]
3632
34989
1.13
3.88
20.3
17.8
%
13.7
13.7
0.04
3559
34200
(3025468) Yersinia sp identified in Specimen by Organism specific culture
92
599
1.55
3.87
1.2
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
94
615
1.54
3.87
1.2
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
964
8562
1.16
3.86
2.9
3.0
mmol/l
2.4
2.5
2.40
855
7504
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
145
1035
1.41
3.86
1.5
1.6
—
—
—
0
0
(3012544) pH of Venous blood
482
4042
1.21
3.82
4.0
3.6
ph
7.4
7.4
—
5
21
(3000475) Leukocytes [#/volume] in Synovial fluid
148
1063
1.40
3.81
1.8
1.6
e6/l
13090.7
11484.4
0.22
108
760
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
24
101
2.38
3.80
1.8
1.8
ug/l
1.2
2.3
3.28
12
56
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
221
1693
1.32
3.77
1.8
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
92
603
1.54
3.77
1.2
1.4
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
13
39
3.34
3.75
1.1
1.1
u/ml
0.0
0.7
—
8
24
(3021901) Oxygen saturation in Capillary blood
112
766
1.47
3.75
2.8
2.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
200
1512
1.34
3.74
2.6
3.0
g/l
0.4
0.3
0.63
89
570
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
24
102
2.36
3.73
2.3
2.3
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
23
96
2.40
3.72
3.3
3.0
mg/l
8.4
7.5
0.28
16
81
(3009214) Lutropin [Units/volume] in Serum or Plasma
108
735
1.48
3.71
1.3
1.3
u/l
12.8
12.6
0.05
89
594
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
59
349
1.70
3.67
1.1
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
37
189
1.96
3.66
1.5
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
91
601
1.52
3.62
1.2
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
766
6722
1.16
3.60
1.9
2.1
s
29.6
29.7
0.20
734
6508
(3044927) Protein electrophoresis panel - Urine
74
467
1.59
3.59
1.2
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
102
692
1.48
3.57
1.1
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
513
4356
1.20
3.57
1.8
1.7
%
1.5
1.5
0.87
452
3795
(3033923) Metanephrine [Moles/time] in 24 hour Urine
22
92
2.40
3.55
1.0
1.1
umol/24h
0.6
0.7
—
8
46
(3025018) Bordetella pertussis Ab [Titer] in Serum
43
234
1.84
3.55
1.3
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
91
604
1.52
3.54
1.2
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
300
2416
1.26
3.49
8.1
9.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
237
1855
1.29
3.48
1.9
1.9
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
25
112
2.24
3.47
1.0
1.1
%
83.8
88.8
0.23
13
61
(3023430) Cat dander IgE Ab [Units/volume] in Serum
60
363
1.66
3.45
1.1
1.1
u/ml
7.3
2.8
0.62
29
139
(3024522) Salmonella sp identified in Specimen by Organism specific culture
91
608
1.51
3.45
1.2
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
127
906
1.41
3.43
2.6
2.8
kpa
8.1
8.1
0.04
117
838
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
216
1675
1.30
3.41
2.8
2.3
g/l
2.9
3.1
3.53
167
1316
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
99
678
1.47
3.33
1.7
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
91
613
1.49
3.33
1.5
1.9
pmol/l
181.4
202.9
1.29
85
578
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
156
1159
1.36
3.32
1.6
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
315
2572
1.24
3.27
1.4
1.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
202
1563
1.30
3.26
3.0
3.9
mmol/l
1.4
1.4
0.03
197
1538
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
45
256
1.76
3.24
1.1
1.1
iu/ml
4.7
11.1
—
9
69
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
30
150
2.01
3.19
1.7
1.5
pmol/l
15.7
15.8
0.01
25
127
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
41
228
1.80
3.19
2.3
2.6
%
39.6
39.4
0.02
24
83
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
68
434
1.57
3.19
1.4
1.3
u/l
40.2
34.5
0.60
60
353
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
24
110
2.19
3.18
1.0
1.3
%
90.6
87.6
0.12
12
61
(3015235) Bicarbonate [Moles/volume] in Capillary blood
144
1065
1.36
3.17
2.7
3.1
mmol/l
24.3
25.1
1.33
122
930
(3014133) Dog dander IgE Ab [Units/volume] in Serum
63
396
1.60
3.15
1.1
1.1
u/ml
1.2
2.9
1.57
30
144
(3019832) Treponema pallidum Ab [Presence] in Serum
257
2060
1.26
3.15
1.6
1.6
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
71
460
1.55
3.13
1.1
1.1
u/ml
2.4
2.1
0.05
21
108
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
142
1051
1.36
3.11
1.3
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
219
1726
1.28
3.09
1.9
2.0
ug/l
2.3
2.1
0.10
184
1529
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
265
3260
0.80
3.06
1.7
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
51
307
1.67
3.03
1.5
1.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
175
1343
1.31
3.02
3.3
4.1
mmol/l
3.8
3.9
0.35
167
1266
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
45
263
1.72
2.98
1.5
2.3
e6/l
426.0
537.0
0.95
39
223
(3027696) Helicobacter pylori Ab [Titer] in Serum
5
5
10.01
2.98
1.0
1.2
titre
1076.0
1740.0
—
5
5
(3052851) Hemolysis interference index of Serum or Plasma
170
1304
1.31
2.95
2.7
3.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
126
924
1.37
2.95
1.3
1.2
mmol/l
3.8
3.8
0.05
116
862
(3020874) Milk IgE Ab [Units/volume] in Serum
32
169
1.90
2.94
1.1
1.1
u/ml
30.6
0.9
—
7
53
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
162
1237
1.32
2.91
1.5
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
155
1177
1.33
2.90
1.7
1.8
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
29
149
1.95
2.89
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
523
4537
1.17
2.87
1.6
1.6
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
31
164
1.90
2.84
1.0
1.0
u/ml
10.1
0.4
—
6
42
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
43
252
1.71
2.84
1.5
2.4
e9/l
0.2
0.2
0.36
38
222
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
426
3637
1.19
2.83
3.5
3.6
ng/l
91.3
90.3
0.07
362
3083
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
166
2138
0.77
2.83
1.6
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
454
3898
1.18
2.83
3.8
3.7
kpa
5.8
5.8
0.03
443
3785
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
74
498
1.49
2.78
1.9
1.5
%
56.9
59.1
0.18
49
306
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
91
638
1.43
2.77
1.3
1.4
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
9
23
3.92
2.77
1.7
2.0
mg/l
33.1
18.9
—
9
23
(3000060) B lymphocytes [#/volume] in Blood
19
84
2.27
2.76
1.4
1.9
e6/l
130.9
138.7
0.08
11
38
(3023511) Choriogonadotropin [Units/volume] in Urine
52
324
1.61
2.74
1.2
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
133
997
1.34
2.73
1.5
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
452
3892
1.18
2.73
3.8
3.7
mmol/l
1.9
2.0
0.33
372
3176
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
140
1058
1.33
2.72
1.4
1.3
mg/l
531.4
537.8
0.07
132
996
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
322
2690
1.21
2.72
3.2
3.6
kpa
5.1
5.2
0.71
292
2496
(3000492) Spirometry study
459
3959
1.18
2.71
1.5
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
103
743
1.39
2.69
1.5
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
311
2594
1.21
2.68
3.9
3.1
g/l
127.3
128.0
0.21
303
2520
(3013945) Hepatitis B virus e Ab [Presence] in Serum
8
19
4.22
2.67
1.0
1.9
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
9
24
3.75
2.67
1.1
1.0
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
617
5454
1.15
2.65
6.3
6.7
mmol/l
104.5
104.3
0.38
602
5336
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
35
198
1.77
2.63
1.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
23
113
2.04
2.61
1.0
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
40
236
1.70
2.60
1.4
1.7
u/l
5.0
7.0
1.52
35
196
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
79
548
1.45
2.57
1.1
1.1
g/l
1.5
1.5
0.01
71
487
(3017354) Segmented neutrophils/100 leukocytes in Blood
64
427
1.51
2.53
3.5
3.4
%
57.8
57.0
0.09
35
277
(44790049)
70
476
1.48
2.53
1.7
1.5
—
—
—
0
0
(44790048)
70
476
1.48
2.53
1.7
1.5
—
—
—
0
0
(44790047)
70
476
1.48
2.53
1.7
1.5
—
—
—
0
0
(44806118)
70
476
1.48
2.53
1.7
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
120
899
1.34
2.50
1.7
1.7
mu/l
289.1
314.2
0.43
107
815
(3037756) Immunofixation for Serum or Plasma
125
943
1.33
2.49
1.7
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
336
2846
1.19
2.48
1.3
1.3
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
8
21
3.81
2.46
1.8
2.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
49
310
1.59
2.46
1.4
1.2
mmol/l
2.1
2.1
0.02
44
289
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
116
869
1.34
2.43
1.7
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
138
1063
1.31
2.39
1.4
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
59
393
1.51
2.37
1.2
1.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
49
313
1.57
2.37
1.8
2.2
%
47.0
40.7
—
5
42
(3009343) pH of Capillary blood
314
2656
1.19
2.36
3.2
3.6
ph
7.4
7.4
0.61
43
337
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
17
4.12
2.36
1.1
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
303
2559
1.20
2.32
3.2
3.6
mmol/l
1.5
1.9
0.89
217
1927
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
15
65
2.31
2.31
1.2
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
130
1000
1.31
2.29
2.4
2.3
ug/min
83.3
96.8
0.22
69
590
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
14
59
2.38
2.29
1.1
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
46
293
1.58
2.27
2.0
1.8
umol/l
9.9
10.8
0.10
37
201
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
23
3.48
2.27
1.1
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
62
422
1.47
2.26
3.5
3.8
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
72
506
1.43
2.23
1.0
1.1
u/ml
7.4
3.9
0.69
40
236
(3040151) Glucose [Moles/volume] in Capillary blood
67
465
1.45
2.22
3.5
5.2
mmol/l
7.4
7.3
0.10
57
385
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
18
86
2.10
2.22
1.9
1.5
ng/l
126.6
115.9
0.16
18
86
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
22
114
1.93
2.20
1.3
1.3
%
41.2
32.9
0.43
12
72
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
91
669
1.37
2.19
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
81
585
1.39
2.17
1.5
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
121
930
1.31
2.16
1.3
1.3
e6/l
25.8
29.9
0.09
93
700
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
23
122
1.89
2.15
1.3
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
368
3185
1.17
2.14
3.3
3.0
kpa
4.5
4.6
0.20
356
3083
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
121
932
1.31
2.13
1.5
1.4
e6/l
794.1
1269.9
0.36
99
742
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
51
338
1.51
2.13
1.0
1.0
mg/l
282.8
292.8
0.46
46
302
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
48
314
1.53
2.13
1.2
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
80
579
1.39
2.12
1.4
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
87
641
1.36
2.08
1.1
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
117
901
1.31
2.08
1.6
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
184
1499
1.24
2.06
2.4
2.2
ug/l
285.3
653.1
1.50
170
1410
(3042517) Benzodiazepines panel - Urine
7
20
3.50
2.05
1.3
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
83
613
1.36
1.97
1.6
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
43
280
1.54
1.97
1.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
81
596
1.36
1.97
1.1
1.1
u/ml
3.7
1.4
0.54
34
232
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
29
171
1.70
1.96
2.1
1.9
ug/l
28.4
21.7
0.47
24
156
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
32
194
1.65
1.96
2.4
2.5
—
31.4
—
0
5
(3020891) Body temperature
213
1773
1.21
1.95
3.6
4.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
92
692
1.34
1.94
1.5
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
181
1487
1.23
1.90
2.7
2.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
46
307
1.50
1.89
1.2
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
40
259
1.55
1.89
1.0
1.0
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
173
1416
1.23
1.88
2.4
2.2
g/l
38.5
37.5
1.40
146
1218
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
76
558
1.37
1.88
1.3
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
66
474
1.40
1.87
1.7
1.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
43
284
1.52
1.86
1.3
1.3
u/ml
1.1
1.2
0.04
16
143
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
128
1014
1.27
1.86
1.2
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
40
260
1.54
1.86
1.0
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
235
1987
1.19
1.84
1.6
1.7
g/l
1.5
1.6
1.28
196
1697
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
28
167
1.68
1.83
1.1
2.1
%
142.1
154.0
0.40
28
155
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
86
650
1.33
1.78
2.3
2.0
u/l
8062.9
3308.4
0.42
29
274
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
11
47
2.34
1.77
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
117
924
1.27
1.76
2.8
2.4
%
16.1
16.1
0.04
67
465
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
286
2470
1.17
1.76
1.4
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
77
574
1.35
1.76
1.3
1.3
nmol/l
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
29
177
1.64
1.75
1.3
5.8
mg/l
56.2
60.6
0.18
20
131
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
173
1430
1.22
1.74
3.4
3.3
ratio
3.3
2.0
—
10
121
(3029396) Erythrocyte agglutination [Presence] in Blood
9
36
2.50
1.74
2.9
3.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
32
201
1.60
1.73
2.6
2.5
mmol/l
8.4
9.4
0.82
20
153
(3008401) Mugwort IgE Ab [Units/volume] in Serum
67
490
1.37
1.73
1.0
1.1
u/ml
2.0
1.4
0.25
31
200
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
20
110
1.82
1.72
1.2
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
7
24
2.92
1.72
1.0
1.4
nmol/l
3.4
4.2
—
7
24
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
11
48
2.29
1.70
1.5
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
40
267
1.50
1.68
1.3
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
29
180
1.61
1.66
1.1
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
20
112
1.79
1.64
1.3
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
35
229
1.53
1.62
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
152
1252
1.22
1.60
1.8
1.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
20
113
1.77
1.60
1.3
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
632
5783
1.11
1.59
5.1
4.6
%
32.3
32.8
0.56
420
3808
(3027974) Hepatitis B virus e Ag [Presence] in Serum
6
20
3.00
1.58
1.0
1.8
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
176
1475
1.20
1.56
3.4
3.3
mg/l
41.2
55.8
0.62
147
1200
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1138
10701
1.08
1.56
2.4
2.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
90
701
1.29
1.55
4.4
3.4
%
1.7
1.4
0.30
63
544
(3049717) Cytology report of Urine Cyto stain
187
1579
1.19
1.54
2.2
2.6
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
76
579
1.32
1.54
4.2
6.6
mg/l
10.5
11.9
1.64
68
537
(3038177) Helicobacter pylori Ab [Presence] in Serum
81
623
1.31
1.53
1.3
1.3
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
89
694
1.29
1.52
2.2
1.9
mmol/l
1.6
1.7
0.35
89
676
(3000012) Reticulocyte production index
35
233
1.51
1.51
1.5
1.5
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
23
139
1.66
1.48
2.1
2.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
175
1476
1.19
1.47
3.5
3.3
mg/l
43.7
95.0
0.73
144
1201
(3045683) HLA typing for celiac disease panel - Blood or Tissue
33
219
1.51
1.45
1.1
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
98
779
1.26
1.45
1.9
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
64
481
1.33
1.44
3.9
4.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
110
888
1.24
1.43
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
110
888
1.24
1.43
1.4
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
40
567
0.70
1.43
3.4
5.1
umol/l
359.4
364.1
0.06
34
498
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
102
817
1.25
1.42
5.3
5.3
iu/ml
147.3
557.0
1.69
16
117
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
151
1261
1.20
1.42
2.6
2.3
g/l
0.0
0.0
0.50
139
1161
(3044640) Blood type and Crossmatch panel - Blood
1469
13993
1.07
1.41
2.4
2.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
33
221
1.50
1.40
1.1
1.1
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
9
40
2.25
1.40
1.3
1.3
—
652.2
—
0
8
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
65
494
1.32
1.37
1.2
1.2
mmol/l
7.7
7.4
0.22
49
369
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
46
331
1.39
1.36
1.3
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
53
391
1.36
1.35
1.1
1.2
nmol/l
392.0
357.7
0.44
33
333
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
47
340
1.39
1.35
1.2
1.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
66
504
1.31
1.35
1.2
1.2
u/l
60.2
58.8
0.06
46
340
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
39
273
1.43
1.34
1.1
1.1
nmol/l
1.3
12.2
—
6
58
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
17
97
1.76
1.34
1.2
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
93
743
1.26
1.34
1.5
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
35
240
1.46
1.34
1.3
1.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
9
42
2.14
1.33
1.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
18
105
1.72
1.33
8.9
8.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
76
594
1.28
1.31
1.9
2.2
mg/l
44.7
24.2
1.45
16
154
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
24
152
1.58
1.31
2.0
2.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
159
1347
1.19
1.30
2.6
2.3
g/l
0.0
0.0
0.23
147
1242
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
179
1532
1.17
1.30
2.6
2.4
g/l
1.1
0.9
0.29
155
1328
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
13
69
1.89
1.28
10.8
7.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
25
161
1.56
1.28
1.1
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
19
114
1.67
1.28
1.3
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
38
268
1.42
1.27
1.6
2.4
e6/l
818.7
683.2
0.28
13
122
(1617658) Protocol used for examination of sentinel lymph nodes
29
425
0.68
1.27
1.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
73
571
1.28
1.26
2.6
2.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
106
867
1.23
1.26
1.3
1.3
—
—
—
0
0
(4034850)
168
1437
1.17
1.24
11.4
9.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
60
459
1.31
1.23
1.7
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
158
1347
1.18
1.22
1.2
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
34
237
1.44
1.22
1.3
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
147
1246
1.19
1.22
2.7
2.3
g/l
0.0
0.0
0.00
136
1159
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
8
37
2.16
1.21
2.6
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
171
1470
1.17
1.20
2.5
3.1
u/ml
0.4
0.4
0.01
98
839
(21494814) CD8 cells/100 lymphocytes in Specimen
25
164
1.53
1.20
2.0
2.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
106
873
1.22
1.19
3.1
2.8
umol/l
34.1
35.0
0.14
90
741
(40768800) Prostate Pathology biopsy report
53
694
0.76
1.19
1.2
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
64
497
1.29
1.19
3.1
2.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
108
892
1.22
1.18
1.3
1.3
miu/ml
261.4
221.9
0.47
41
392
(21494755) Public health laboratory ask at order entry panel
272
3051
0.89
1.18
1.3
1.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
38
2.11
1.18
1.4
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
8
39
2.05
1.15
1.1
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
8
39
2.05
1.15
1.3
2.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
219
1928
1.14
1.13
3.2
3.7
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
31
216
1.44
1.13
1.1
1.3
u/l
487.3
281.5
0.28
24
199
(3001686) Cold agglutinin [Titer] in Serum or Plasma
14
80
1.75
1.12
1.2
1.3
—
120.3
—
0
13
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
139
1183
1.18
1.12
2.3
2.5
g/l
3.6
3.5
0.20
131
1121
(3028707) Methadone [Presence] in Urine by Screen method
48
363
1.33
1.09
2.1
2.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
18
280
0.64
1.08
1.4
1.7
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
307
2769
1.12
1.08
7.6
8.6
%
1.4
1.4
0.15
302
2754
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
22
144
1.53
1.08
1.5
1.7
ug/l
0.5
0.4
0.69
14
90
(3010503) CD19 cells [#/volume] in Blood
36
261
1.38
1.07
1.9
2.4
e9/l
0.2
0.3
0.18
36
250
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
16
97
1.65
1.06
1.0
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
296
2668
1.12
1.06
1.8
1.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
412
3778
1.10
1.06
3.6
3.9
mmol/l
1.2
1.2
0.64
362
3283
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
67
533
1.26
1.06
1.1
1.1
u/ml
2.6
3.8
0.42
19
209
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
94
777
1.21
1.05
1.3
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
65
516
1.26
1.05
1.9
1.8
ug/l
14.6
25.1
3.12
60
509
(3042111) Morphology [Interpretation] in Bone marrow Narrative
94
778
1.21
1.04
1.7
1.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
64
508
1.26
1.03
3.1
2.3
mmol/l
4.0
4.1
0.12
64
500
(3035285) Chloride [Moles/volume] in Venous blood
64
508
1.26
1.03
3.1
2.3
mmol/l
105.9
105.3
0.50
64
500
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
5
22
2.27
1.03
1.0
1.0
u/field
1.0
0.9
—
5
13
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
53
411
1.29
1.03
1.1
1.1
—
85.0
—
0
5
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
7
34
2.06
1.02
1.1
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
54
420
1.29
1.02
1.1
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
17
106
1.61
1.02
1.1
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
43
325
1.33
1.00
1.3
1.2
titre
325.0
172.0
—
6
59
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
43
325
1.33
1.00
1.0
1.0
u/ml
0.9
0.3
—
9
80
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
48
369
1.30
1.00
1.1
1.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
25
172
1.46
0.99
2.0
2.1
%
8.4
8.5
0.01
25
164
(3023323) Follitropin [Units/volume] in Serum or Plasma
148
1284
1.16
0.97
1.5
1.3
iu/l
28.3
34.9
1.93
133
1102
(3028433) Virus identified in Specimen by Culture
21
140
1.50
0.97
1.2
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
16
100
1.60
0.96
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
16
100
1.60
0.96
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
16
100
1.60
0.96
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
16
100
1.60
0.96
1.0
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
125
1072
1.17
0.95
2.5
3.0
mg/l
1.7
1.6
0.37
111
973
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
44
337
1.31
0.95
1.3
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
25
174
1.44
0.95
4.2
2.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
58
461
1.26
0.95
1.8
1.4
mosm/kgh2o
281.5
276.5
1.11
42
355
(3038071) Oxygen [Partial pressure] in Mixed venous blood
15
93
1.61
0.93
9.7
8.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
6
27
2.22
0.93
1.2
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
22
150
1.47
0.92
1.7
1.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
39
295
1.32
0.92
1.3
1.5
promille
1.4
1.1
0.46
32
229
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
70
571
1.23
0.92
1.2
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
66
535
1.24
0.92
1.9
2.5
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
29
210
1.38
0.90
1.1
1.1
u/l
1.1
1.1
0.05
11
111
(3016750) Collection duration of Urine
32
236
1.36
0.89
2.1
2.2
min
484.8
493.6
0.19
21
177
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
52
412
1.26
0.88
1.6
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
122
1053
1.16
0.88
2.5
2.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
42
324
1.30
0.87
2.4
2.3
ml
701.4
625.0
0.37
25
216
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
79
657
1.21
0.87
1.3
1.3
nmol/l
0.6
3.0
0.69
74
632
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
54
431
1.26
0.87
3.1
3.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
214
1921
1.12
0.87
2.6
2.6
%
0.7
0.6
0.53
206
1840
(3047007) Chlamydophila sp Ab [Presence] in Serum
69
567
1.22
0.86
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
65
532
1.22
0.84
1.6
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
124
1076
1.16
0.84
1.9
1.8
iu/l
6.0
4.9
0.31
38
368
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
29
213
1.36
0.84
1.4
1.6
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
20
137
1.46
0.84
1.3
1.2
g/l
38.0
39.1
0.10
11
64
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
36
274
1.32
0.83
1.1
1.2
mg/l
44.4
40.3
0.20
31
232
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
36
274
1.32
0.83
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
73
606
1.21
0.83
2.8
2.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
31
231
1.34
0.82
1.2
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
31
231
1.34
0.82
1.2
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
31
231
1.34
0.82
1.2
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
31
231
1.34
0.82
1.2
1.8
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
8
46
1.74
0.82
1.0
1.1
umol/24h
1.7
1.7
—
8
46
(3045424) Erythrocytes [Presence] in Urine
89
754
1.18
0.82
1.4
1.5
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
6
32
1.88
0.81
1.3
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
20
138
1.45
0.81
2.0
2.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
64
526
1.22
0.81
2.9
3.3
nmol/l
6.7
5.7
0.12
59
515
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
21
294
0.71
0.79
2.0
1.8
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
187
1677
1.12
0.79
3.4
3.9
mmol/l
24.6
25.0
0.88
173
1551
(3014271) Vancomycin [Susceptibility]
31
233
1.33
0.79
3.1
2.8
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
31
233
1.33
0.79
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
31
233
1.33
0.79
1.3
1.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
11
66
1.67
0.78
1.2
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
24
173
1.39
0.78
1.1
1.1
ng/l
91.1
433.2
—
7
42
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
45
357
1.26
0.78
1.1
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
99
0.50
0.77
1.2
1.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
69
575
1.20
0.77
2.0
1.8
%
90.2
89.5
0.35
69
566
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
100
0.50
0.77
1.0
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
56
457
1.23
0.77
1.8
2.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
53
430
1.24
0.76
1.1
1.1
—
5.0
—
0
6
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
286
2628
1.09
0.76
2.9
3.9
u/ml
36.6
62.5
2.43
273
2525
(44806420)
19
132
1.44
0.75
2.7
2.3
—
—
—
0
0
(4281824)
45
560
0.80
0.75
1.2
1.2
—
—
—
0
0
(44806071)
9
53
1.70
0.75
1.1
1.1
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
5
24
2.08
0.74
1.2
1.3
—
1.2
—
0
6
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
5
24
2.08
0.74
2.0
1.9
—
0.2
—
0
5
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
62
743
0.83
0.73
1.4
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
48
388
1.24
0.72
1.4
1.4
%
26.1
30.4
0.43
32
237
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
7
39
1.80
0.72
1.0
1.2
u/l
6.1
17.8
—
7
39
(1761868) Lipid panel - Serum or Plasma
1398
14425
0.96
0.72
3.3
3.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
50
407
1.23
0.71
4.7
5.0
u/ml
112.6
91.5
0.10
14
114
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
47
380
1.24
0.71
1.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
47
380
1.24
0.71
1.2
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
47
380
1.24
0.71
1.2
1.6
—
—
—
0
0
(3036603) Volume of Urine
37
291
1.27
0.70
1.3
1.5
ml
1487.5
1921.9
—
8
59
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
58
696
0.83
0.70
1.4
1.2
u/ml
300.8
281.4
0.21
36
422
(3027231) Wheat IgE Ab [Units/volume] in Serum
9
58
1.55
0.69
1.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
55
455
1.21
0.68
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
165
1830
0.90
0.68
1.7
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
26
196
1.33
0.67
1.3
2.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
53
438
1.21
0.67
1.4
1.3
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
7
43
1.63
0.66
3.1
2.6
u/field
0.7
0.5
—
7
43
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
441
4151
1.07
0.66
2.4
2.4
u/l
46.6
50.3
0.08
374
3532
(3012501) Base excess in Blood by calculation
111
977
1.14
0.66
3.8
4.3
mmol/l
2.4
2.7
0.62
90
684
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
28
1.79
0.66
1.2
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
108
950
1.14
0.65
3.5
3.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
40
494
0.81
0.65
1.1
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
48
394
1.22
0.65
1.1
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
556
5855
0.94
0.65
1.3
1.3
—
—
—
0
0
(4027681)
27
206
1.31
0.65
1.3
1.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
7
44
1.59
0.65
1.9
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
35
277
1.27
0.65
1.5
1.6
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
5
29
1.72
0.64
1.2
1.1
u/l
—
4.7
—
0
8
(3023410) Appearance of Cerebral spinal fluid
50
414
1.21
0.63
1.4
1.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
10
63
1.59
0.61
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
123
1098
1.12
0.61
3.3
3.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
111
985
1.13
0.60
1.3
1.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
5.1
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
20
0.00
0.60
0.0
1.0
—
89.2
—
0
14
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
21
0.00
0.60
0.0
7.1
—
129.1
—
0
16
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
30
236
1.27
0.59
1.2
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
52
1.54
0.59
1.3
1.3
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
32
254
1.26
0.59
1.1
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
32
254
1.26
0.59
1.1
1.1
u/l
16.5
24.7
0.85
25
187
(3048929) Epstein Barr virus Ab [Presence] in Serum
89
1013
0.88
0.59
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
46
381
1.21
0.59
1.2
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
6
35
1.72
0.57
1.0
1.3
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
6
35
1.72
0.57
1.2
1.3
mmol/l
123.0
148.3
—
6
30
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
70
604
1.16
0.57
1.3
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
67
577
1.16
0.56
1.1
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
30
238
1.26
0.56
2.0
3.3
ph
7.4
7.4
—
9
78
(40768441) Liver Pathology biopsy report
39
320
1.22
0.55
1.3
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
69
597
1.16
0.55
1.5
1.4
mu/l
41.0
50.0
0.38
60
528
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
31
382
0.81
0.52
2.6
2.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
39
469
0.83
0.52
1.5
1.5
e6/l
84313.4
60041.3
0.15
22
277
(3051387) C reactive protein [Mass/volume] in Capillary blood
83
939
0.88
0.52
4.1
3.6
mg/l
19.5
27.0
2.07
57
570
(3000285) Sodium [Moles/volume] in Blood
9
63
1.43
0.52
1.1
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
58
673
0.86
0.52
1.5
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
29
232
1.25
0.52
1.2
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
97
0.62
0.52
1.0
1.6
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
40
1.50
0.51
1.7
2.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
31
380
0.81
0.51
1.6
1.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
9
65
1.39
0.50
1.7
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
26
324
0.80
0.49
1.5
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
34
411
0.83
0.49
1.4
1.5
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
45
1.56
0.49
1.0
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
90
803
1.12
0.48
1.6
1.8
nmol/l
0.9
0.8
0.39
66
674
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
13
93
1.40
0.48
1.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
110
1215
0.90
0.47
1.3
1.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
64
560
1.14
0.46
1.3
1.3
pmol/l
313.1
329.2
0.09
56
434
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
25
200
1.25
0.46
1.7
1.8
nmol/l
2.8
6.5
0.89
20
168
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
50
430
1.16
0.46
1.8
1.7
—
—
—
0
0
(4015189)
17
129
1.32
0.45
2.6
2.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
83
0.60
0.45
1.8
1.2
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
31
255
1.22
0.45
1.1
1.1
u/l
80.1
78.7
0.04
26
193
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
44
375
1.17
0.45
1.3
1.3
nmol/l
1.4
1.5
0.21
37
339
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
50
1.40
0.45
1.0
1.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
25
308
0.81
0.44
2.3
2.1
ug/l
1.6
2.3
0.68
17
263
(3010421) pH of Blood
126
1153
1.10
0.44
3.7
4.1
ph
7.4
7.4
0.04
109
959
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
30
247
1.22
0.44
1.2
1.1
ratio
1.1
1.1
0.58
14
78
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
35
293
1.20
0.44
1.2
1.3
mmol/l
11.2
12.0
—
6
78
(3013727) Leukocytes other/100 leukocytes in Blood
18
139
1.30
0.43
6.8
3.6
%
46.1
53.2
0.59
18
133
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
126
1156
1.09
0.42
2.4
2.4
%
188.1
195.7
0.42
115
1100
(3047189) Immunofixation for 24 hour Urine
17
218
0.78
0.42
1.3
1.7
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
5
32
1.56
0.42
1.4
1.1
—
12.2
—
0
9
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
57
1.40
0.42
2.9
1.9
umol/l
10.3
19.2
—
8
57
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
108
1183
0.91
0.41
1.2
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
31
370
0.84
0.41
1.3
1.2
—
—
—
0
0
(37019676) Renin [Units/volume] in Plasma --supine
0
15
0.00
0.41
0.0
1.1
—
22.5
—
0
7
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
15
0.00
0.41
0.0
4.9
—
386.9
—
0
15
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
37
314
1.18
0.41
1.5
1.5
u/l
2.6
5.8
2.21
18
147
(46236302) HLA-C [Type] by High resolution typing
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
0.1
—
0
9
(40763590) HLA-DQ beta [Type]
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
17
0.00
0.40
0.0
2.9
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1146
11193
1.03
0.40
3.8
3.8
%
91.9
90.8
0.81
1108
10903
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
19
150
1.27
0.40
2.0
2.5
umol/l
27.1
29.1
0.43
14
110
(3042951) Complement C1q Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
17.7
—
0
5
(3010937) Rubella virus Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3013862) HLA-DP [Type]
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
4.5
—
3.1
—
0
13
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
12
88
1.36
0.40
1.1
1.3
mg/l
0.7
53.9
—
7
66
(3039443) Prostate specific Ag panel - Serum or Plasma
55
624
0.88
0.39
1.7
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
26
214
1.22
0.39
3.9
4.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
16
124
1.29
0.38
1.9
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
21
169
1.24
0.38
2.6
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
5
36
1.39
0.38
1.6
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
54
476
1.14
0.38
1.7
2.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
16
203
0.79
0.37
1.3
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
30
355
0.84
0.37
1.5
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
35
299
1.17
0.37
2.7
2.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
30
354
0.85
0.36
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
30
353
0.85
0.36
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
30
353
0.85
0.36
1.5
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
19
153
1.24
0.35
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
15
117
1.28
0.35
1.1
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
43
1.40
0.35
1.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
134
0.75
0.34
1.1
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10
73
1.37
0.34
1.5
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
44
1.36
0.34
1.3
1.6
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
44
1.36
0.34
1.2
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
14
178
0.79
0.34
1.1
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
18
145
1.24
0.33
1.4
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
34
293
1.16
0.33
7.1
6.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
15
118
1.27
0.33
1.8
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
89
816
1.09
0.33
1.7
1.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
19
155
1.23
0.32
1.1
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
27
229
1.18
0.32
2.0
1.8
u/field
3.7
2.0
0.69
21
155
(4133840)
12
92
1.31
0.31
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
14
110
1.27
0.31
1.3
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
19
230
0.83
0.31
1.3
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
21
174
1.21
0.31
1.1
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
52
1.35
0.31
1.0
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
17
208
0.82
0.31
1.1
1.7
ug/l
2.2
4.6
—
9
158
(3020491) Glucose [Moles/volume] in Blood
35
305
1.15
0.30
1.5
2.2
mmol/l
7.0
6.9
0.02
18
196
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
18
147
1.23
0.30
1.3
1.1
miu/ml
1896.7
1585.9
0.59
18
147
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
19
229
0.83
0.30
1.4
1.4
pmol/l
62.6
185.6
—
9
75
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
7
54
1.30
0.30
8.0
6.5
ug/min
36.7
48.4
—
7
45
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
69
629
1.10
0.30
1.3
1.2
u/ml
3.8
3.3
0.08
21
202
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
14
111
1.26
0.30
1.3
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
55
1.27
0.30
3.6
2.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
135
1267
1.07
0.29
2.2
2.1
%
90.0
92.1
0.50
127
1180
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
19
228
0.83
0.29
1.6
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
25
213
1.17
0.29
8.2
12.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
130
1.23
0.28
2.3
3.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
130
1.23
0.28
2.3
3.6
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
24
204
1.18
0.28
6.5
5.1
u/ml
2964.8
56.7
—
6
35
(3051611) Lipemic interference index of Serum or Plasma
51
459
1.11
0.28
2.8
3.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
47
523
0.90
0.28
1.4
1.5
e6/l
1128.2
2069.1
1.92
31
392
(40761536) Microorganisms panel - Urine sediment
352
3646
0.96
0.27
4.8
4.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
26
301
0.86
0.27
1.6
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
95
884
1.08
0.27
3.4
3.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
20
168
1.19
0.27
2.5
2.3
umol/l
51.2
54.8
0.32
13
130
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
10
128
0.78
0.26
1.0
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
219
2289
0.95
0.26
9.2
9.1
mmol/l
24.2
24.4
0.27
196
2145
(3034891) Synovial lining cells/100 cells in Synovial fluid
22
187
1.18
0.26
1.6
1.4
%
3.7
3.5
—
7
40
(3032057) Clostridioides difficile [Presence] in Stool
13
104
1.25
0.26
1.9
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
21
178
1.18
0.26
1.3
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
21
178
1.18
0.26
1.3
1.9
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
72
0.69
0.26
1.2
1.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
17
141
1.21
0.26
1.1
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
25
216
1.16
0.25
1.2
1.2
nmol/l
147.1
133.5
0.63
25
216
(3002619) Bacteria identified in Specimen by Culture
9
73
1.23
0.25
1.6
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
73
675
1.08
0.25
1.4
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
9
75
1.20
0.25
1.0
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
13
159
0.82
0.24
1.2
1.6
—
—
—
0
0
(4146454)
56
512
1.09
0.24
3.2
2.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
39
434
0.90
0.24
1.5
1.7
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
10
78
1.28
0.24
1.5
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
88
822
1.07
0.24
1.7
1.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
88
822
1.07
0.24
1.3
1.3
mmol/l
63.1
61.8
0.11
69
662
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
21
180
1.17
0.23
1.3
1.9
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
22
190
1.16
0.23
4.1
3.1
mu/l
35.6
27.8
0.31
22
183
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
177
1693
1.05
0.23
3.4
3.2
u/ml
617.5
3524.2
1.03
144
1433
(40765096) Chromosome analysis panel by Banding
16
134
1.19
0.22
1.1
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
24
209
1.15
0.22
1.4
2.2
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5
40
1.25
0.22
1.0
1.1
—
9.6
—
0
8
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
41
1.22
0.22
1.2
1.0
—
—
—
0
0
(3036489) Thrombin time
164
1568
1.05
0.22
2.0
2.0
s
21.5
21.5
0.05
141
1374
(3028300) Cannabinoids [Presence] in Urine
88
826
1.07
0.22
1.7
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
637
6239
1.02
0.22
2.9
3.0
ug/l
0.8
0.8
0.01
405
4160
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
24
210
1.14
0.21
4.6
3.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
86
807
1.07
0.21
1.7
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
109
1031
1.06
0.21
1.4
1.7
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
2.3
—
0
10
(3006567) Chloride [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
43
1.16
0.21
1.2
1.3
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
11
89
1.24
0.21
1.1
1.1
—
—
—
0
0
(4024509)
52
479
1.09
0.20
1.9
1.6
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
26
230
1.13
0.20
2.2
2.2
ug/min
95.6
264.7
—
5
50
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
35
316
1.11
0.20
1.9
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
16
136
1.18
0.20
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
26
292
0.89
0.20
1.5
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
51
1.18
0.19
1.0
1.0
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
36
327
1.10
0.19
1.1
1.0
ng/l
324.2
335.9
0.09
24
222
(3024471) HLA-A [Type]
14
118
1.19
0.19
1.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
48
519
0.92
0.18
1.0
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
18
156
1.15
0.18
2.6
2.3
e6/l
371.7
846.7
1.38
12
109
(3005033) Fetal Nuchal fold Thickness US
26
290
0.90
0.18
1.5
1.4
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
7
58
1.21
0.18
4.0
3.1
—
28.8
—
0
8
(3027456) Digoxin [Moles/volume] in Serum or Plasma
98
931
1.05
0.18
2.9
3.2
nmol/l
0.8
0.8
0.46
73
711
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
59
1.19
0.18
1.6
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
7
60
1.17
0.17
1.4
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
83
785
1.06
0.17
1.6
1.4
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
36
329
1.09
0.17
1.1
1.0
ng/l
889.6
703.6
1.40
25
216
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
7
61
1.15
0.17
1.0
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
(4268621)
46
426
1.08
0.17
2.5
2.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1130
11167
1.02
0.17
1.4
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
68
0.74
0.17
1.0
1.5
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
17
148
1.15
0.16
1.4
1.4
%
59.5
63.4
0.14
12
124
(3003434) Protein [Mass/volume] in Pleural fluid
54
577
0.94
0.16
1.4
1.5
g/l
34.9
32.1
0.78
47
522
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
78
0.77
0.15
1.0
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
119
0.84
0.15
1.2
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
79
1.14
0.15
1.1
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
36
332
1.08
0.15
1.1
1.0
ng/l
42.6
45.3
0.15
24
221
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
26
286
0.91
0.15
1.1
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
16
140
1.14
0.15
1.2
1.3
—
—
—
0
0
(4094501)
127
1224
1.04
0.14
1.1
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
73
694
1.05
0.14
1.6
1.4
u/ml
113.1
118.6
0.23
21
140
(3000991) Gas panel - Venous blood
363
3558
1.02
0.14
7.5
8.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
38
354
1.07
0.13
2.6
2.1
u/field
3.5
2.2
0.37
19
136
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
106
0.85
0.13
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
49
519
0.94
0.12
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
26
239
1.09
0.12
1.4
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
52
493
1.06
0.11
1.0
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
11
95
1.16
0.11
1.1
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
13
147
0.88
0.11
1.2
1.2
g/l
—
0.3
—
0
11
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
508
5012
1.02
0.11
3.4
3.9
ug/l
34.3
23.6
0.19
393
4071
(3000034) Microalbumin [Mass/volume] in Urine
44
416
1.06
0.11
2.5
2.8
mg/l
73.5
27.4
0.64
31
299
(3003129) Base excess in Capillary blood by calculation
13
115
1.13
0.10
1.6
1.9
mmol/l
-0.5
1.5
1.06
13
108
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
65
624
1.04
0.09
1.2
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
45
1.11
0.09
1.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
46
1.09
0.09
2.2
1.6
umol/l
35.2
43.9
—
5
46
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
22
203
1.08
0.09
1.1
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
48
1.04
0.09
3.2
2.2
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
6
56
1.07
0.08
1.0
1.9
mmol/l
1.5
2.9
—
6
45
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
469
4637
1.01
0.08
3.5
3.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
33
312
1.06
0.08
1.3
1.5
g/l
1.0
1.0
0.06
33
312
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
60
0.83
0.08
1.6
3.9
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
62
0.81
0.08
2.0
1.5
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
65
0.77
0.08
2.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
14
127
1.10
0.07
1.6
2.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
14
127
1.10
0.07
1.4
1.8
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
8
75
1.07
0.07
1.8
2.8
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
8
78
1.03
0.07
6.8
6.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
26
245
1.06
0.07
1.1
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
122
0.90
0.07
1.3
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
87
1.03
0.07
1.2
2.6
—
—
—
0
0
(4035726)
417
4212
0.99
0.07
1.4
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
10
89
1.12
0.06
1.2
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
17
183
0.93
0.06
9.5
11.7
mmol/l
0.5
0.6
1.05
17
170
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
13
142
0.92
0.06
1.1
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
109
1.10
0.06
1.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
33
345
0.96
0.06
1.2
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
63
612
1.03
0.06
1.1
1.1
iu/ml
83.4
78.4
0.03
13
133
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
64
622
1.03
0.06
1.4
1.2
u/ml
2.2
4.3
2.55
31
251
(3045142) Bone marrow Pathology biopsy report
54
524
1.03
0.05
1.2
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
43
445
0.97
0.05
1.5
1.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
22
232
0.95
0.05
1.2
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
18
169
1.07
0.05
1.4
2.3
umol/l
35.1
143.0
—
7
98
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
120
1.08
0.04
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
158
1559
1.01
0.04
1.1
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
103
1012
1.02
0.04
2.7
3.4
u/ml
820.8
694.3
0.06
96
918
(3016879) Cocaine [Presence] in Urine
77
754
1.02
0.04
1.7
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
23
219
1.05
0.04
1.2
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
23
219
1.05
0.04
1.2
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
21
221
0.95
0.04
3.9
3.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
62
634
0.98
0.04
1.5
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
41
422
0.97
0.03
1.3
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
13
121
1.07
0.03
1.0
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
13
139
0.94
0.03
1.8
2.1
e6/l
2081.9
21947.3
—
8
76
(3051651) Icteric interference index of Serum or Plasma
25
260
0.96
0.03
3.4
3.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
29
280
1.04
0.03
1.1
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
12
112
1.07
0.03
4.8
5.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
41
419
0.98
0.02
1.4
1.5
nmol/l
0.2
0.3
0.18
31
305
(3035880) pH of Pleural fluid
25
242
1.03
0.02
1.5
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
93
1.08
0.02
1.3
1.8
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
59
599
0.98
0.02
1.2
1.1
%
121.1
117.1
0.50
53
529
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
13
137
0.95
0.01
1.2
1.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
381
3797
1.00
0.01
6.4
6.7
mmol/l
1.4
1.3
0.84
368
3671
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
23
224
1.03
0.00
1.2
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
71
716
0.99
0.00
1.2
1.2
u/l
23.4
40.6
1.82
57
619
(3020650) Glucose [Presence] in Urine
11
105
1.05
0.00
1.5
1.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
12
115
1.04
0.00
1.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
34
338
1.01
0.00
2.0
2.0
%
12.0
11.0
0.84
34
338
(3012441) Differential panel - Pleural fluid
42
422
1.00
0.00
1.4
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
145
1445
1.00
0.00
2.0
1.7
mg/l
5.3
3.8
0.54
110
1053
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
11
114
0.96
0.00
1.3
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
21
206
1.02
0.00
2.6
2.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
113
0.97
0.00
1.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
123
0.98
0.00
1.4
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
16
157
1.02
0.00
1.4
1.4
—
1472393.8
—
0
8
(4306422)
62
623
1.00
0.00
1.3
1.2
—
—
—
0
0
(4198724)
11
109
1.01
0.00
4.1
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
83
827
1.00
0.00
2.9
3.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
13
131
0.99
0.00
3.1
2.2
—
—
—
0
0
(4211845)
24
241
1.00
0.00
3.6
3.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
198
1981
1.00
0.00
3.4
4.0
mmol/l
23.9
24.3
1.23
171
1779
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
6
0.00
0.00
0.0
7.3
—
70.5
—
0
6
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
9
90
1.00
0.00
1.1
1.7
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
5
56
0.89
0.00
2.4
3.8
umol/l
24.4
42.9
—
5
45
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
67
0.90
0.00
1.5
1.5
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
8
0.00
0.00
0.0
1.5
—
2736.2
—
0
8
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
8
82
0.98
0.00
1.0
1.1
—
4.9
—
0
13
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
49
1.02
0.00
7.0
9.9
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
52
0.96
0.00
1.0
1.0
—
—
—
0
0
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
17.8
—
0
5
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
1.2
—
0
8
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
49
1.02
0.00
3.2
2.2
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
5
0.00
0.00
0.0
1.8
—
6.8
—
0
5
(3024869) Neuronal Ab [Presence] in Serum
7
74
0.95
0.00
1.0
1.1
—
—
—
0
0
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: L12_LICHENPLANUS – Lichen planus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).